# EDGAR Filing Document

**Accession Number:** 0001672013
**File Stem:** 0001672013-26-000112
**Filing Date:** 2026-5
**Character Count:** 150643
**Document Hash:** 6c9d8324a28249e00d4dab2cd134be9a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001672013-26-000112.hdr.sgml**: 20260506

**ACCESSION NUMBER**: 0001672013-26-000112

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 83

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260506

**DATE AS OF CHANGE**: 20260506

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Acushnet Holdings Corp.
- **CENTRAL INDEX KEY:** 0001672013
- **STANDARD INDUSTRIAL CLASSIFICATION:** [3949]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 455644353
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37935
- **FILM NUMBER:** 26948387

**BUSINESS ADDRESS:**
- **STREET 1:** 333 BRIDGE STREET
- **CITY:** FAIRHAVEN
- **STATE:** MA
- **ZIP:** 02719
- **BUSINESS PHONE:** 800-225-8500

**MAIL ADDRESS:**
- **STREET 1:** 333 BRIDGE STREET
- **CITY:** FAIRHAVEN
- **STATE:** MA
- **ZIP:** 02719

?xml version='1.0' encoding='ASCII'? golf-20260331

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u><br>

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, DC 20549**

---

| | |
|:---|:---|
| **Form** | **10-Q** |

---

☒**&nbsp;&nbsp;&nbsp;&nbsp;QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended March 31, 2026** 

**or**

☐**&nbsp;&nbsp;&nbsp;&nbsp;TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from to&nbsp;&nbsp;&nbsp;&nbsp;**

**Commission file number: 001-37935** 

---

| |
|:---|
| **Acushnet Holdings Corp.** |
| (Exact name of registrant as specified in its charter) |

---

---

| | | | |
|:---|:---|:---|:---|
| **Delaware** | | | **45-2644353** |
| (State or other jurisdiction of incorporation or organization) | | | (I.R.S. Employer Identification No.) |
| **333 Bridge Street** | **Fairhaven,** | **Massachusetts** | **02719** |
| (Address of principal executive offices) | | | (Zip Code) |

---

**(800) 225-8500** 

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock - $0.001 par value per share | GOLF | New York Stock Exchange |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The registrant had 58,554,053 shares of common stock outstanding as of April 30, 2026.

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

**ACUSHNET HOLDINGS CORP.**

**FORM 10-Q**

**FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2026** 

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| | | **Page No.** |
| <u>[PART I.](#i26ac3c2f0d24498d958d61e65856c20f_13)</u> | <u>[FINANCIAL INFORMATION](#i26ac3c2f0d24498d958d61e65856c20f_13)</u> | <u>[4](#i26ac3c2f0d24498d958d61e65856c20f_13)</u> |
| &nbsp;&nbsp;&nbsp;<u>[Item 1.](#i26ac3c2f0d24498d958d61e65856c20f_16)</u> | <u>[Financial Statements](#i26ac3c2f0d24498d958d61e65856c20f_16)</u> | <u>[4](#i26ac3c2f0d24498d958d61e65856c20f_16)</u> |
| &nbsp;&nbsp;&nbsp;<u>[Item 2.](#i26ac3c2f0d24498d958d61e65856c20f_106)</u> | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i26ac3c2f0d24498d958d61e65856c20f_106)</u> | <u>[25](#i26ac3c2f0d24498d958d61e65856c20f_106)</u> |
| &nbsp;&nbsp;&nbsp;<u>[Item 3.](#i26ac3c2f0d24498d958d61e65856c20f_124)</u> | <u>[Quantitative and Qualitative Disclosures About Market Risk](#i26ac3c2f0d24498d958d61e65856c20f_124)</u> | <u>[34](#i26ac3c2f0d24498d958d61e65856c20f_124)</u> |
| &nbsp;&nbsp;&nbsp;<u>[Item 4.](#i26ac3c2f0d24498d958d61e65856c20f_127)</u> | <u>[Controls and Procedures](#i26ac3c2f0d24498d958d61e65856c20f_127)</u> | <u>[35](#i26ac3c2f0d24498d958d61e65856c20f_127)</u> |
| <u>[PART II.](#i26ac3c2f0d24498d958d61e65856c20f_130)</u> | <u>[OTHER INFORMATION](#i26ac3c2f0d24498d958d61e65856c20f_130)</u> | <u>[36](#i26ac3c2f0d24498d958d61e65856c20f_130)</u> |
| &nbsp;&nbsp;&nbsp;<u>[Item 1.](#i26ac3c2f0d24498d958d61e65856c20f_133)</u>  | <u>[Legal Proceedings](#i26ac3c2f0d24498d958d61e65856c20f_133)</u> | <u>[36](#i26ac3c2f0d24498d958d61e65856c20f_133)</u> |
| &nbsp;&nbsp;&nbsp;<u>[Item 1A.](#i26ac3c2f0d24498d958d61e65856c20f_136)</u> | <u>[Risk Factors](#i26ac3c2f0d24498d958d61e65856c20f_136)</u> | <u>[36](#i26ac3c2f0d24498d958d61e65856c20f_136)</u> |
| &nbsp;&nbsp;&nbsp;<u>[Item 2.](#i26ac3c2f0d24498d958d61e65856c20f_139)</u> | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i26ac3c2f0d24498d958d61e65856c20f_139)</u> | <u>[36](#i26ac3c2f0d24498d958d61e65856c20f_139)</u> |
| &nbsp;&nbsp;&nbsp;<u>[Item 3.](#i26ac3c2f0d24498d958d61e65856c20f_142)</u> | <u>[Defaults Upon Senior Securities](#i26ac3c2f0d24498d958d61e65856c20f_142)</u> | <u>[36](#i26ac3c2f0d24498d958d61e65856c20f_142)</u> |
| &nbsp;&nbsp;&nbsp;<u>[Item 4.](#i26ac3c2f0d24498d958d61e65856c20f_145)</u> | <u>[Mine Safety Disclosures](#i26ac3c2f0d24498d958d61e65856c20f_145)</u> | <u>[36](#i26ac3c2f0d24498d958d61e65856c20f_145)</u> |
| &nbsp;&nbsp;&nbsp;<u>[Item 5.](#i26ac3c2f0d24498d958d61e65856c20f_148)</u> | <u>[Other Information](#i26ac3c2f0d24498d958d61e65856c20f_148)</u> | <u>[36](#i26ac3c2f0d24498d958d61e65856c20f_148)</u> |
| &nbsp;&nbsp;&nbsp;<u>[Item 6.](#i26ac3c2f0d24498d958d61e65856c20f_151)</u> | <u>[Exhibits](#i26ac3c2f0d24498d958d61e65856c20f_151)</u> | <u>[37](#i26ac3c2f0d24498d958d61e65856c20f_151)</u> |
| <u>[Signatures](#i26ac3c2f0d24498d958d61e65856c20f_154)</u> | <u>[Signatures](#i26ac3c2f0d24498d958d61e65856c20f_154)</u> | <u>[38](#i26ac3c2f0d24498d958d61e65856c20f_154)</u> |

---

1

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

In this Quarterly Report on Form 10-Q, the terms "Acushnet," "we," "us," "our" and the "Company" refer to Acushnet Holdings Corp. and its consolidated subsidiaries.

**SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS**

The forward-looking statements contained in this report are based on management's current expectations and are subject to uncertainty and changes in circumstances. We cannot assure you that future developments affecting us will be those that we have anticipated. Actual results may differ materially from these expectations due to changes in global, regional or local economic, business, competitive, market, regulatory, political and other factors, many of which are beyond our control. We believe that these factors include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a reduction in the number of rounds of golf played or in the number of golf participants;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• unfavorable weather conditions may impact the number of playable days and rounds played in a given year;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• consumer spending habits and macroeconomic and demographic factors may affect the number of rounds of golf played, the number of golf participants and related spending on golf products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• U.S. and foreign trade policies, including the assessment of tariffs and other impositions on imported goods;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes to the Rules of Golf with respect to equipment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to successfully manage the frequent introduction of new products or satisfy changing consumer preferences and quality and regulatory standards;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our reliance on technical innovation and high-quality products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a significant disruption in the operations of our manufacturing, assembly or distribution facilities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to procure, and the cost of, raw materials and product components;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a disruption in the operations of our suppliers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• currency transaction and translation risk;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to adequately enforce and protect our intellectual property rights;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our involvement in lawsuits to protect, defend or enforce our intellectual property rights;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the risk that our products may infringe the intellectual property rights of others;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes to patent laws;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• intense competition and our ability to maintain a competitive advantage in each of our markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• limited opportunities for future growth in sales of certain of our products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our customers' financial conditions, levels of business activity and ability to pay their trade obligations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a decrease in corporate spending on our custom logo golf balls;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to maintain and further develop our sales channels;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• consolidation of retailers or concentration of retail market share;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to maintain and enhance our brands;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• fluctuations of our business and results of operations due to seasonality and product launch cycles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks associated with doing business globally;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• compliance with applicable anti-bribery, anti-money laundering and economic sanctions laws;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to secure professional golfers to endorse or use our products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• negative publicity relating to us, the golfers who use our products or the golf industry in general;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to accurately forecast demand for our products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a disruption in the service, or a significant increase in the cost, of our primary delivery and shipping services or a significant disruption at shipping ports;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to successfully manage the implementation of our new enterprise resource planning platform;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to maintain our information systems to adequately perform their functions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• cybersecurity risks;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks and challenges associated with the development and use of artificial intelligence;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to comply with data privacy and security laws;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the ability of our eCommerce systems to function effectively;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• impairment of goodwill and identifiable intangible assets;

2

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to attract and/or retain management and other key employees and hire qualified management, technical and manufacturing personnel;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to prohibit sales of our products by unauthorized retailers or distributors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to grow our presence in existing international markets and expand into additional international markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• tax uncertainties, including potential changes in tax laws, unanticipated tax liabilities and limitations on utilization of tax attributes after any change of control;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to secure and maintain adequate levels of coverage under our insurance policies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• product liability, warranty and recall claims;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• litigation and other regulatory proceedings;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• compliance with environmental, health and safety laws and regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to secure additional capital at all or on terms acceptable to us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• lack of assurance of positive returns on capital investments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks associated with acquisitions and investments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• terrorist activities and international political instability;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• occurrence of natural disasters or pandemic diseases;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a high degree of leverage, ability to service our indebtedness, ability to incur more indebtedness and restrictions in the agreements governing our indebtedness;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our use of derivative financial instruments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the interests of our controlling shareholder and its affiliates may conflict with the interests of our other shareholders;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our status as a controlled company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the execution of our share repurchase program and effects thereof;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to pay dividends;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• dilution from future issuances or sales of our common stock;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• anti-takeover provisions in our organizational documents and Delaware law; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• other factors discussed under the heading "Risk Factors" in our most recent Annual Report on Form 10-K and in any other reports we file with the Securities and Exchange Commission (the "SEC"), including this Quarterly Report on Form 10-Q.

These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this report. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, our actual results may vary in material respects from those projected in these forward-looking statements.

Any forward-looking statement made by us in this report speaks only as of the date of this report. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, investments or other strategic transactions we may pursue. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws.

3

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

**PART I.&nbsp;&nbsp;&nbsp;&nbsp; FINANCIAL INFORMATION**

***ITEM 1.****&nbsp;&nbsp;&nbsp;&nbsp;* ***FINANCIAL STATEMENTS***

**INDEX TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

---

| | |
|:---|:---|
| | **Page(s)** |
| **Unaudited Condensed Consolidated Financial Statements** | |
| <u>[Condensed Consolidated Balance Sheets (unaudited)](#i26ac3c2f0d24498d958d61e65856c20f_19)</u> | <u>[5](#i26ac3c2f0d24498d958d61e65856c20f_19)</u> |
| <u>[Condensed Consolidated Statements of Operations (unaudited)](#i26ac3c2f0d24498d958d61e65856c20f_22)</u> | <u>[6](#i26ac3c2f0d24498d958d61e65856c20f_22)</u> |
| <u>[Condensed Consolidated Statements of Comprehensive Income (unaudited)](#i26ac3c2f0d24498d958d61e65856c20f_25)</u> | <u>[7](#i26ac3c2f0d24498d958d61e65856c20f_25)</u> |
| <u>[Condensed Consolidated Statements of Cash Flows (unaudited)](#i26ac3c2f0d24498d958d61e65856c20f_28)</u> | <u>[8](#i26ac3c2f0d24498d958d61e65856c20f_28)</u> |
| <u>[Condensed Consolidated Statements of Shareholders' Equity (unaudited)](#i26ac3c2f0d24498d958d61e65856c20f_34)</u> | <u>[9](#i26ac3c2f0d24498d958d61e65856c20f_34)</u> |
| <u>[Notes to Unaudited Condensed Consolidated Financial Statements](#i26ac3c2f0d24498d958d61e65856c20f_37)</u> | <u>[10](#i26ac3c2f0d24498d958d61e65856c20f_40)</u> |

---

4

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

**ACUSHNET HOLDINGS CORP.**

**CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)**

---

| | | |
|:---|:---|:---|
| | **March 31,** | **December 31,** |
| ***(in thousands, except share and per share amounts)*** | **2026** | **2025** |
| **Assets** |  |  |
| Current assets |  |  |
| &nbsp;&nbsp;Cash, cash equivalents and restricted cash ($852 and $0 attributable to a variable interest entity ("VIE")) | $51679 | $50088 |
| &nbsp;&nbsp;&nbsp;Accounts receivable, net | 504764 | 217480 |
| &nbsp;&nbsp;Inventories ($3,411 and $0 attributable to a VIE) | 576722 | 608571 |
| &nbsp;&nbsp;&nbsp;Prepaid and other current assets | 162130 | 149232 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 1295295 | 1025371 |
| Property, plant and equipment, net | 360078 | 356575 |
| Goodwill | 223056 | 224258 |
| Intangible assets, net | 509156 | 511430 |
| Deferred income taxes | 14252 | 21081 |
| Other assets | 198065 | 203984 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $2599902 | $2342699 |
| **Liabilities, Redeemable Noncontrolling Interests and Shareholders' Equity** |  |  |
| Current liabilities |  |  |
| &nbsp;&nbsp;&nbsp;Short-term debt | $27962 | $16005 |
| &nbsp;&nbsp;&nbsp;Current portion of long-term debt | 650 | 661 |
| &nbsp;&nbsp;Accounts payable ($2,849 and $0 attributable to a VIE) | 179561 | 156984 |
| &nbsp;&nbsp;&nbsp;Accrued taxes | 47182 | 34219 |
| &nbsp;&nbsp;&nbsp;Accrued compensation and benefits | 66028 | 100975 |
| &nbsp;&nbsp;&nbsp;Accrued expenses and other liabilities | 130629 | 121310 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 452012 | 430154 |
| Long-term debt | 1122410 | 926244 |
| Deferred income taxes | 11881 | 7604 |
| Accrued pension and other postretirement benefits | 67000 | 68756 |
| Other noncurrent liabilities ($1,500 and $0 attributable to a VIE) | 119969 | 124605 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 1773272 | 1557363 |
| Commitments and contingencies (Note 15) |  |  |
| Redeemable noncontrolling interests | 1595 | 1770 |
| Shareholders' equity |  |  |
| Common stock, $0.001 par value, 500,000,000 shares authorized; 58,548,082 and 58,371,822 shares issued | 59 | 58 |
| &nbsp;&nbsp;Additional paid-in capital | 751491 | 763828 |
| &nbsp;&nbsp;Accumulated other comprehensive loss, net of tax | (125603) | (122281) |
| &nbsp;&nbsp;Retained earnings | 199165 | 141961 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total equity attributable to Acushnet Holdings Corp. | 825112 | 783566 |
| &nbsp;&nbsp;&nbsp;Noncontrolling interests | (77) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity | 825035 | 783566 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities, redeemable noncontrolling interests and shareholders' equity | $2599902 | $2342699 |

---

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

**ACUSHNET HOLDINGS CORP.**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)**

---

| | | |
|:---|:---|:---|
| | **Three months ended March 31,** | **Three months ended March 31,** |
| ***(in thousands, except share and per share amounts)*** | **2026** | **2025** |
| Net sales | $752975 | $703372 |
| Cost of goods sold | 397715 | 366210 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 355260 | 337162 |
| Operating expenses: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative | 213671 | 200261 |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development | 19195 | 18859 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intangible amortization | 2245 | 3495 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income from operations | 120149 | 114547 |
| Interest expense, net | 13072 | 13815 |
| Other expense (income), net | 1816 | (19863) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income before income taxes | 105261 | 120595 |
| Income tax expense | 24101 | 21570 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income | 81160 | 99025 |
| Less: Net loss attributable to noncontrolling interests | 256 | 347 |
| Net income attributable to Acushnet Holdings Corp. | $81416 | $99372 |
| Net income per common share attributable to Acushnet Holdings Corp.: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $1.36 | $1.62 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | 1.36 | 1.62 |
| Weighted average number of common shares: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | 59845676 | 61325623 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | 60009105 | 61484788 |

---

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

6

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

**ACUSHNET HOLDINGS CORP.**

**CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)**

---

| | | |
|:---|:---|:---|
| | **Three months ended March 31,** | **Three months ended March 31,** |
| ***(in thousands)*** | **2026** | **2025** |
| Net income | $81160 | $99025 |
| Other comprehensive (loss) income: |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency translation adjustments | (6297) | 8894 |
| &nbsp;&nbsp;&nbsp;Cash flow derivative instruments: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Unrealized holding gains (losses) arising during period | 2679 | (2160) |
| &nbsp;&nbsp;&nbsp;&nbsp;Reclassification adjustments included in net income | 498 | (414) |
| &nbsp;&nbsp;&nbsp;&nbsp;Tax (expense) benefit | (794) | 739 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash flow derivative instruments, net | 2383 | (1835) |
| &nbsp;&nbsp;&nbsp;Pension and other postretirement benefits: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Pension and other postretirement benefits adjustments | 776 | (645) |
| &nbsp;&nbsp;&nbsp;&nbsp;Tax (expense) benefit | (183) | 127 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pension and other postretirement benefits adjustments, net | 593 | (518) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other comprehensive (loss) income | (3321) | 6541 |
| Comprehensive income | 77839 | 105566 |
| Less: Comprehensive loss attributable to noncontrolling interests | 255 | 269 |
| &nbsp;&nbsp;&nbsp;&nbsp;Comprehensive income attributable to Acushnet Holdings Corp. | $78094 | $105835 |

---

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

7

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

**ACUSHNET HOLDINGS CORP.**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)**

---

| | | |
|:---|:---|:---|
| | **Three months ended March 31,** | **Three months ended March 31,** |
| ***(in thousands)*** | **2026** | **2025** |
| **Cash flows from operating activities** |  |  |
| Net income | $81160 | $99025 |
| Adjustments to reconcile net income to cash flows used in operating activities |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 12869 | 14277 |
| &nbsp;&nbsp;&nbsp;Unrealized foreign exchange loss (gain) | 1923 | (2085) |
| &nbsp;&nbsp;&nbsp;Amortization of debt issuance costs | 329 | 452 |
| &nbsp;&nbsp;&nbsp;Share-based compensation | 8580 | 6941 |
| &nbsp;&nbsp;&nbsp;Loss on disposals of property, plant and equipment | 30 | 385 |
| &nbsp;&nbsp;Gain on deconsolidation of VIE (Note 16) |  | (20887) |
| &nbsp;&nbsp;Loss from equity method investment (Note 16) | 66 | 223 |
| &nbsp;&nbsp;&nbsp;Deferred income taxes | 9712 | 4885 |
| &nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | (290737) | (254549) |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 27916 | 42496 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 27996 | 35926 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued taxes | 14005 | 14483 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets and liabilities | (37512) | (61826) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash flows used in operating activities | (143663) | (120254) |
| **Cash flows from investing activities** |  |  |
| Additions to property, plant and equipment | (19191) | (11263) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash flows used in investing activities | (19191) | (11263) |
| **Cash flows from financing activities** |  |  |
| Proceeds from credit facilities (Note 5) | 444524 | 401522 |
| Repayments of credit facilities (Note 5) | (235598) | (223230) |
| Purchases of common stock | (9977) | (35683) |
| Dividends paid on common stock | (15874) | (14778) |
| Payment of employee restricted stock tax withholdings | (19667) | (9686) |
| Other, net | 1500 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash flows provided by financing activities | 164908 | 118145 |
| Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash | (463) | 912 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net increase (decrease) in cash, cash equivalents and restricted cash | 1591 | (12460) |
| Cash, cash equivalents and restricted cash, beginning of year | 50088 | 53059 |
| Cash, cash equivalents and restricted cash, end of period | $51679 | $40599 |
| **Supplemental non-cash information** |  |  |
| Purchases of property, plant and equipment, accrued not paid | $4283 | $2439 |
| Additions to right-of-use assets obtained in exchange for operating lease obligations | 2502 | 5345 |
| Dividend equivalents rights ("DERs") declared not paid | 646 | 506 |
| Additions to share repurchase liability (Note 10) |  | 36637 |
| Additional investment in less than wholly-owned subsidiary (Note 16) | 6361 |  |

---

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

8

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

**ACUSHNET HOLDINGS CORP.**

**CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Common Stock** | **Common Stock** | **Additional<br>Paid-in<br>Capital** | **Accumulated<br>Other<br>Comprehensive<br>Loss, <br>Net of Tax** | **Retained<br>Earnings** | **Treasury Stock** | **Total<br>Shareholders'<br>Equity<br>Attributable<br>to Acushnet<br>Holdings Corp.** | **Noncontrolling<br>Interests** | **Total<br>Shareholders'<br>Equity** |
| ***(in thousands)*** | **Shares** | **Amount** | **Additional<br>Paid-in<br>Capital** | **Accumulated<br>Other<br>Comprehensive<br>Loss, <br>Net of Tax** | **Retained<br>Earnings** | **Treasury Stock** | **Total<br>Shareholders'<br>Equity<br>Attributable<br>to Acushnet<br>Holdings Corp.** | **Noncontrolling<br>Interests** | **Total<br>Shareholders'<br>Equity** |
| **Balances as of December 31, 2024** | 61215 | $61 | $787725 | $(140315) | $180276 | $(62500) | $765247 | $27889 | $793136 |
| Net income (loss) |  |  |  |  | 99372 |  | 99372 | (188) | 99184 |
| Other comprehensive income |  |  |  | 6463 |  |  | 6463 |  | 6463 |
| Share-based compensation |  |  | 6941 |  |  |  | 6941 |  | 6941 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vesting of restricted common stock, including impact of DERs, <br>net of shares withheld for employee taxes (Note 11) | 247 |  | (9686) |  |  |  | (9686) |  | (9686) |
| Purchases of common stock (Note 10) | (541) |  | (6909) |  | (29931) |  | (36840) |  | (36840) |
| Share repurchase liability (Note 10) |  |  |  |  |  | (36637) | (36637) |  | (36637) |
| Dividends and dividend equivalents declared |  |  |  |  | (14576) |  | (14576) |  | (14576) |
| Deconsolidation of VIE (Note 16) |  |  |  |  |  |  |  | (27701) | (27701) |
| **Balances as of March 31, 2025** | 60921 | $61 | $778071 | $(133852) | $235141 | $(99137) | $780284 | $— | $780284 |
| **Balances as of December 31, 2025** | 58372 | $58 | $763828 | $(122281) | $141961 | $— | $783566 | $— | $783566 |
| Capital contribution from noncontrolling interests (Note 16) |  |  |  |  |  |  |  | 3 | 3 |
| Net income (loss) |  |  |  |  | 81416 |  | 81416 | (80) | 81336 |
| Other comprehensive loss |  |  |  | (3322) |  |  | (3322) |  | (3322) |
| Share-based compensation |  |  | 8580 |  |  |  | 8580 |  | 8580 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vesting of restricted common stock, including impact of DERs, <br>net of shares withheld for employee taxes (Note 11) | 282 | 1 | (19557) |  |  |  | (19556) |  | (19556) |
| Purchases of common stock (Note 10) | (106) |  | (1360) |  | (8617) |  | (9977) |  | (9977) |
| Dividends and dividend equivalents declared |  |  |  |  | (15595) |  | (15595) |  | (15595) |
| **Balances as of March 31, 2026** | 58548 | $59 | $751491 | $(125603) | $199165 | $— | $825112 | $(77) | $825035 |

---

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

9

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

**ACUSHNET HOLDINGS CORP.**

**NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**1. Summary of Significant Accounting Policies**

**Basis of Presentation**

The accompanying unaudited condensed consolidated financial statements of Acushnet Holdings Corp. (the "Company") have been prepared in conformity with accounting principles generally accepted in the United States ("U.S. GAAP"). These unaudited condensed consolidated financial statements include the accounts of the Company and Acushnet Company, including Acushnet Company's wholly-owned subsidiaries and less than wholly-owned subsidiaries, which include VIEs in which Acushnet Company is the primary beneficiary. In addition, investments in entities over which the Company has significant influence but not control are accounted for using the equity method of accounting. The Company conducts substantially all its business through Acushnet Company and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

Certain information in footnote disclosures normally included in annual financial statements has been condensed or omitted for the interim periods presented in accordance with the rules and regulations of the SEC and U.S. GAAP. The year-end balance sheet data was derived from audited financial statements; however, the accompanying interim notes to the unaudited condensed consolidated financial statements do not include all disclosures required by U.S. GAAP. In the opinion of management, the financial statements contain all normal and recurring adjustments necessary to state fairly the financial position and results of operations of the Company. The results of operations for the three months ended March 31, 2026 are not necessarily indicative of results to be expected for the full year ending December 31, 2026, nor were those of the comparable 2025 periods representative of those actually experienced for the full year ended December 31, 2025. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements and related notes for the fiscal year ended December 31, 2025 included in its Annual Report on Form 10-K filed with the SEC on February 27, 2026.

**Use of Estimates**

The preparation of the Company's unaudited condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect reported amounts of assets and liabilities and related disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

**Variable Interest Entities**

VIEs are entities that, by design, either (i) lack sufficient equity to permit the entity to finance its activities independently, or (ii) have equity holders that do not have the power to direct the activities of the entity that most significantly impact its economic performance, the obligation to absorb the entity's expected losses, or the right to receive the entity's expected residual returns. The Company consolidates a VIE when it is the primary beneficiary, which is the party that has both (i) the power to direct the activities that most significantly impact the VIE's economic performance and (ii) through its interests in the VIE, the obligation to absorb expected losses or the right to receive expected benefits from the VIE that could potentially be significant to the VIE. The Company presents separately on its unaudited condensed consolidated balance sheets, to the extent material, the assets of consolidated VIEs that can only be used to settle specific obligations of the consolidated VIEs and the liabilities of consolidated VIEs for which creditors do not have recourse to its general credit. See Note 16 for additional information regarding other business developments impacting VIEs.

10

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

**Equity Method Investments**

The Company uses the equity method of accounting for equity investments if the investment enables the Company to exercise significant influence, but not control, over operating and financial policies of the investee. The Company's proportionate share of the net income or loss of these investees is included in consolidated net income (loss). The Company evaluates equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable. An impairment that is other-than-temporary is recognized in the period identified. See Note 16 for additional information regarding other business developments impacting equity method investments.

**Noncontrolling Interests and Redeemable Noncontrolling Interests**

The ownership interests held by owners other than the Company in less than wholly-owned subsidiaries are classified as noncontrolling interests. The financial results and position of noncontrolling interests are included in the Company's unaudited condensed consolidated financial statements. The value attributable to the noncontrolling interests is presented on the unaudited condensed consolidated balance sheets, separately from the equity attributable to the Company. Net income (loss) and comprehensive income (loss) attributable to noncontrolling interests are presented separately on the unaudited condensed consolidated statements of operations and unaudited condensed consolidated statements of comprehensive income, respectively.

Redeemable noncontrolling interests are those noncontrolling interests which are or may become redeemable at a fixed or determinable price on a fixed or determinable date, at the option of the holder, or upon occurrence of an event. The Company initially records the redeemable noncontrolling interest at its acquisition date fair value. The carrying amount of the redeemable noncontrolling interest is subsequently adjusted to the greater amount of either the initial carrying amount, increased or decreased for the redeemable noncontrolling interest's share of comprehensive income (loss) or the redemption value, assuming the noncontrolling interest is redeemable at the balance sheet date. This adjustment is recognized through retained earnings and is not reflected in net income (loss) or comprehensive income (loss). The value attributable to redeemable noncontrolling interests and any related loans to minority shareholders, which are recorded as a reduction to redeemable noncontrolling interests, are presented in the unaudited condensed consolidated balance sheets as temporary equity between liabilities and shareholders' equity. The amount of the loan to minority shareholders was $4.4 million as of both March 31, 2026 and December 31, 2025. See Note 16 for additional information regarding other business developments impacting noncontrolling interests.

**Cash, Cash Equivalents and Restricted Cash**

Cash held in Company checking accounts is included in cash. Cash equivalents consist of short-term highly liquid investments with original maturities of three months or less which are readily convertible into cash. The Company classifies as restricted certain cash that is not available for use in its operations. As of March 31, 2026 and December 31, 2025, the amount of restricted cash included in cash, cash equivalents and restricted cash on the unaudited condensed consolidated balance sheets was $1.3 million and $1.4 million, respectively.

**Foreign Currency Transactions**

Foreign currency transaction (losses) gains included in selling, general and administrative expenses were losses of $1.8 million and gains of $1.4 million for the three months ended March 31, 2026 and 2025, respectively.

**Recently Issued Accounting Standards**

***Expense Disaggregation Disclosures***

In November 2024, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2024-03, *"Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40)."* The amendments in this update require disclosure, in the notes to financial statements, of specified information about certain costs and expenses. ASU 2024-03 is effective for annual periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact this standard will have on its consolidated financial statements and related disclosures.

11

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

***Codification Improvements***

In December 2025, the FASB issued ASU 2025-12, "*Codification Improvements."* The amendments in this update refine existing guidance to further enhance the interpretation and application of the codification. The transition method of this update may vary on an issue-by-issue basis. ASU 2025-12 is effective for annual and interim periods beginning after December 15, 2026. Early adoption is permitted on an issue-by-issue basis. The Company is currently evaluating the impact this standard will have on its consolidated financial statements and related disclosures.

**2. Allowance for Credit Losses** 

The Company estimates expected credit losses using a number of factors, including customer credit ratings, age of receivables, historical credit loss information and current economic conditions, which could affect the collectability of the reported amounts. All these factors have been considered in the estimate of expected credit losses for the periods presented.

The activity related to the allowance for credit losses was as follows:

---

| | | |
|:---|:---|:---|
| | **March 31,** | **March 31,** |
| ***(in thousands)*** | **2026** | **2025** |
| **Balance at beginning of period** | $7319 | $7238 |
| Decrease in provision for expected credit losses | (1290) | (920) |
| Amount of receivables (written off) recovered | (149) | 91 |
| Foreign currency translation | (31) | 124 |
| **Balance at end of period** | $5849 | $6533 |

---

 **3. Inventories**

The components of inventories were as follows:

---

| | | |
|:---|:---|:---|
| | **March 31,** | **December 31,** |
| ***(in thousands)*** | **2026** | **2025** |
| Raw materials and supplies | $162492 | $145663 |
| Work-in-process | 33446 | 31570 |
| Finished goods | 380784 | 431338 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | $576722 | $608571 |

---

**4. Product Warranty**

The Company has defined warranties generally ranging from one to two years. Products covered by the defined warranty policies primarily include all Titleist golf products, FootJoy golf shoes and FootJoy golf outerwear. These product warranties generally obligate the Company to pay for the cost of replacement products, including the cost of shipping replacement products to its customers. The estimated cost of satisfying future warranty claims is accrued at the time the sale is recorded. In estimating future warranty obligations, the Company considers various factors, including its warranty policies and practices, the historical frequency of claims and the cost to replace or repair products under warranty.

The activity related to the Company's warranty obligation for accrued warranty expense was as follows:

---

| | | |
|:---|:---|:---|
| | **March 31,** | **March 31,** |
| ***(in thousands)*** | **2026** | **2025** |
| **Balance at beginning of period** | $6062 | $4980 |
| Provision | 2002 | 1441 |
| Claims paid/costs incurred | (1635) | (1266) |
| Foreign currency translation | (53) | 35 |
| **Balance at end of period** | $6376 | $5190 |

---

12

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

**5. Debt and Financing Arrangements**

**Multi-Currency Revolving Credit Facility**

The Company's credit agreement, dated as of December 23, 2019, as subsequently amended (the "Credit Agreement"), provides for a $950.0 million multi-currency revolving credit facility, due to mature on November 24, 2030. The Credit Agreement, together with related security, guarantee and other agreements, is referred to as the "Revolving Credit Facility."

The Credit Agreement contains customary affirmative and restrictive covenants, including, among others, financial covenants based on the Company's leverage and interest coverage ratios. The Credit Agreement also includes customary events of default, the occurrence of which, following any applicable cure period, would permit the lenders to, among other things, declare the principal, accrued interest and other obligations to be immediately due and payable. As of March 31, 2026, the Company was in compliance with all covenants under the Credit Agreement.

As of March 31, 2026 and December 31, 2025, there were $627.6 million and $431.3 million, respectively, in outstanding borrowings under the Revolving Credit Facility, with a weighted average interest rate of 4.91% and 5.06%, respectively. As of March 31, 2026, the Company had available borrowing capacity under the Revolving Credit Facility of $318.4 million after giving effect to $4.0 million of outstanding letters of credit.

**Senior Notes**

As of March 31, 2026 and December 31, 2025, Acushnet Company had 5.625% senior unsecured notes due December 1, 2033 (the "Notes") outstanding in the aggregate principal balance of $500.0 million. The fair value of the Notes, based on third-party quotes (Level 2), as of March 31, 2026 and December 31, 2025 was $495.8 million and $505.0 million, respectively.

The Notes bear interest at a stated interest rate of 5.625% (an effective interest rate of 5.788%) per year, with interest payable semi-annually on June 1 and December 1 of each year. Accrued interest related to the Notes of $9.9 million and $2.9 million was included within accrued expenses and other liabilities on the unaudited condensed consolidated balance sheets as of March 31, 2026 and December 31, 2025, respectively.

The indenture that governs the Notes (the "Indenture") contains covenants that, among other things, limit the ability of the Company and its subsidiaries to incur liens securing indebtedness for borrowed money, enter into sale and leaseback transactions, and consolidate or merge with or into other companies. As of March 31, 2026, the Company was in compliance with all covenants under the Indenture.

**Other Short-Term Borrowings** 

The Company has certain unsecured and uncommitted local credit facilities available through its subsidiaries. Amounts outstanding under these other short-term borrowings are presented in short-term debt in the unaudited condensed consolidated balance sheets with the proceeds and repayments presented on a gross basis in the unaudited condensed consolidated statements of cash flows. There were $28.0 million and $16.0 million in outstanding borrowings under the Company's local credit facilities as of March 31, 2026 and December 31, 2025, respectively. The weighted average interest rate applicable to the outstanding borrowings was 1.37% and 0.88% as of March 31, 2026 and December 31, 2025, respectively. As of March 31, 2026, the Company had available borrowing capacity under these local credit facilities of $24.8 million.

**Letters of Credit** 

As of March 31, 2026 and December 31, 2025, there were outstanding letters of credit related to agreements, including those issued under the Revolving Credit Facility, totaling $6.8 million and $6.9 million, respectively, of which $4.0 million was secured as of both March 31, 2026 and December 31, 2025. These agreements provided a maximum commitment for letters of credit of $58.8 million as of March 31, 2026.

13

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

**6. Derivative Financial Instruments**

The Company principally uses derivative financial instruments to reduce the impact of foreign currency fluctuations on the Company's results of operations. The principal derivative financial instruments the Company enters into are foreign exchange forward contracts. The Company does not enter into derivative financial instrument contracts for trading or speculative purposes.

**Foreign Exchange Derivative Instruments**

Foreign exchange forward contracts are foreign exchange derivative instruments primarily used to reduce foreign currency risk related to transactions denominated in a currency other than functional currency. These instruments are designated as cash flow hedges. The periods of the foreign exchange forward contracts correspond to the periods of the hedged forecasted transactions, which do not exceed 24 months subsequent to the latest balance sheet date. The primary foreign exchange forward contracts pertain to the U.S. dollar, the Japanese yen, the British pound sterling, the Canadian dollar, the Korean won, the Australian dollar and the euro. The gross U.S. dollar equivalent notional amount outstanding of all foreign exchange forward contracts designated under hedge accounting as of March 31, 2026 and December 31, 2025 was $257.8 million and $230.7 million, respectively.

**Impact on Financial Statements**

The fair value of hedge instruments recognized on the unaudited condensed consolidated balance sheets was as follows:

---

| | | | |
|:---|:---|:---|:---|
| ***(in thousands)*** | | | |
| **Balance Sheet Location** |<br>**Hedge Instrument Type** | **March 31,**<br>**2026** | **December 31,**<br>**2025** |
| Prepaid and other current assets | Foreign exchange forward | $4881 | $2950 |
| Accrued expenses and other liabilities | Foreign exchange forward | 1360 | 1746 |

---

The hedge instrument gains (losses) recognized in accumulated other comprehensive loss, net of tax was as follows:

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 31,** | **March 31,** |
| ***(in thousands)*** | **2026** | **2025** |
| **Type of hedge** |  |  |
| Foreign exchange forward | $2679 | $(2160) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $2679 | $(2160) |

---

Gains and losses on derivative instruments designated as cash flow hedges are reclassified from accumulated other comprehensive loss, net of tax at the time the forecasted hedged transaction impacts the statements of operations or at the time the hedge is determined to be ineffective. Based on the current valuation, during the next 12 months the Company expects to reclassify a net gain of $3.7 million related to foreign exchange derivative instruments from accumulated other comprehensive loss, net of tax, into cost of goods sold. For further information related to amounts recognized in accumulated other comprehensive loss, net of tax, see Note 12.

14

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

The hedge instrument gains (losses) recognized on the unaudited condensed consolidated statements of operations were as follows:

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 31,** | **March 31,** |
| ***(in thousands)*** | **2026** | **2025** |
| **Location of gains (losses) in statements of operations** |  |  |
| Foreign exchange forward: |  |  |
| &nbsp;&nbsp;&nbsp;Cost of goods sold | $(498) | $411 |
| &nbsp;&nbsp;Selling, general and administrative <sup>(1)</sup> | 816 | (960) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $318 | $(549) |

---

_______________________________________________________________________________

<sup>(1)</sup> Relates to net gains (losses) on foreign exchange forward contracts derived from previously designated cash flow hedges.

**Credit Risk**

The Company enters into derivative contracts with major financial institutions with investment grade credit ratings and is exposed to credit losses in the event of non-performance by these financial institutions. This credit risk is generally limited to the unrealized gains in the derivative contracts. However, the Company monitors the credit quality of these financial institutions, as well as its own credit quality, and considers the risk of counterparty default to be minimal.

**7. Fair Value Measurements**

Certain assets and liabilities are carried at fair value under U.S. GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.

Assets and liabilities measured at fair value on a recurring basis as of March 31, 2026 were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fair Value Measurements as of** | **Fair Value Measurements as of** | **Fair Value Measurements as of** | |
| | **March 31, 2026 using:** | **March 31, 2026 using:** | **March 31, 2026 using:** | |
| ***(in thousands)*** | **Level 1** | **Level 2** | **Level 3** | **Balance Sheet Location** |
| **Assets** | | | | |
| Rabbi trust | $2771 | $— | $— | Prepaid and other current assets |
| Foreign exchange derivative instruments |  | 4881 |  | Prepaid and other current assets |
| Deferred compensation program assets | 687 |  |  | Other assets |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $3458 | $4881 | $— |  |
| **Liabilities** |  |  |  |  |
| Foreign exchange derivative instruments | $— | $1360 | $— | Accrued expenses and other liabilities |
| Deferred compensation program liabilities | 687 |  |  | Other noncurrent liabilities |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $687 | $1360 | $— |  |

---

Assets and liabilities measured at fair value on a recurring basis as of December 31, 2025 were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fair Value Measurements as of** | **Fair Value Measurements as of** | **Fair Value Measurements as of** | |
| | **December 31, 2025 using:** | **December 31, 2025 using:** | **December 31, 2025 using:** | |
| ***(in thousands)*** | **Level 1** | **Level 2** | **Level 3** | **Balance Sheet Location** |
| **Assets** | | | | |
| Rabbi trust | $2906 | $— | $— | Prepaid and other current assets |
| Foreign exchange derivative instruments |  | 2950 |  | Prepaid and other current assets |
| Deferred compensation program assets | 719 |  |  | Other assets |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $3625 | $2950 | $— |  |
| **Liabilities** |  |  |  |  |
| Foreign exchange derivative instruments | $— | $1746 | $— | Accrued expenses and other liabilities |
| Deferred compensation program liabilities | 719 |  |  | Other noncurrent liabilities |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $719 | $1746 | $— |  |

---

Rabbi trust assets are used to fund certain retirement obligations of the Company. The assets underlying the Rabbi trust are equity and fixed income exchange-traded funds.

15

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

Deferred compensation program assets and liabilities represent a program where select employees could defer compensation until termination of employment. Effective July 29, 2011, this program was amended to cease all employee compensation deferrals and provided for the distribution of all previously deferred employee compensation. The program remains in effect with respect to the value attributable to the employer match contributed prior to July 29, 2011.

Foreign exchange derivative instruments are foreign exchange forward contracts primarily used to limit currency risk that would otherwise result from changes in foreign exchange rates (Note 6). The Company used the mid-price of foreign exchange forward rates as of the close of business on the valuation date to value each foreign exchange forward contract at each reporting period.

**8. Pension and Other Postretirement Benefits**

Components of net periodic benefit cost (credit) were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Pension Benefits** | **Pension Benefits** | **Postretirement Benefits** | **Postretirement Benefits** |
| | **Three months ended March 31,** | **Three months ended March 31,** | **Three months ended March 31,** | **Three months ended March 31,** |
| ***(in thousands)*** | **2026** | **2025** | **2026** | **2025** |
| **Components of net periodic benefit cost (credit)** |  |  |  |  |
| Service cost | $1045 | $1279 | $89 | $90 |
| Interest cost | 2599 | 2892 | 129 | 143 |
| Expected return on plan assets | (1758) | (2017) |  |  |
| Settlement expense | 682 |  |  |  |
| Amortization of net loss (gain) | 100 | 67 | (200) | (237) |
| Amortization of prior service cost (credit) | 18 | 22 |  | (1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net periodic benefit cost (credit) | $2686 | $2243 | $18 | $(5) |

---

The non-service cost components of net periodic benefit cost (credit) are included in other expense (income), net in the unaudited condensed consolidated statements of operations.

**9. Income Taxes**

Income tax expense increased by $2.5 million to $24.1 million for the three months ended March 31, 2026 compared to $21.6 million for the three months ended March 31, 2025. The Company's effective income tax rate ("ETR") was 22.9% for the three months ended March 31, 2026 compared to 17.9% for the three months ended March 31, 2025.

The ETR for the three months ended March 31, 2026 differed from the U.S. statutory tax rate primarily due to the U.S taxation of foreign income, state income taxes and the Company's jurisdictional mix of earnings, partially offset by the impact of the U.S. deduction for foreign derived intangible income and federal and state tax credits. The ETR for the three months ended March 31, 2025 differed from the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income and federal and state tax credits, partially offset by the U.S. taxation of foreign income, state income taxes and the Company's jurisdictional mix of earnings.

16

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

**10. Common Stock**

**Dividends**

The Company declared dividends per common share, including DERs (Note 11), during the periods presented as follows:

---

| | | |
|:---|:---|:---|
| | **Dividends per Common Share** | **Amount<br>*(in thousands)*** |
| &nbsp;&nbsp;&nbsp;2026: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;First Quarter | $0.255 | $15595 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total dividends declared in 2026 | $0.255 | $15595 |
| &nbsp;&nbsp;&nbsp;2025: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fourth Quarter | $0.235 | $14112 |
| &nbsp;&nbsp;&nbsp;&nbsp;Third Quarter | 0.235 | 14388 |
| &nbsp;&nbsp;&nbsp;&nbsp;Second Quarter | 0.235 | 14298 |
| &nbsp;&nbsp;&nbsp;&nbsp;First Quarter | 0.235 | 14576 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total dividends declared in 2025 | $0.940 | $57374 |

---

During the second quarter of 2026, the Company's board of directors declared a dividend of $0.255 per share of common stock to shareholders of record as of June 5, 2026 and payable on June 22, 2026.

**Share Repurchase Program**

As of March 31, 2026, the board of directors had authorized the Company to repurchase up to $1.25 billion of its issued and outstanding common stock since the share repurchase program was established in 2018. This program may be extended or otherwise modified by the board of directors at any time and will remain in effect until completed or until terminated by the board of directors. Share repurchases may be effected from time to time in open market or privately negotiated transactions, including transactions with affiliates, with the timing of purchases and the amount of stock purchased generally determined at the discretion of the Company consistent with the Company's general working capital needs and within the constraints of the Credit Agreement (Note 5).

On June 14, 2024, the Company entered into an agreement with Magnus Holdings Co., Ltd. ("Magnus"), to purchase from Magnus an equal amount of its common stock as it purchases on the open market over the period of time from July 1, 2024 through December 31, 2024, up to an aggregate of $62.5 million, at the same weighted average per share price (the "June 2024 Agreement"). On April 10, 2025, the Company purchased 935,907 shares of its common stock from Magnus for an aggregate of $62.5 million in satisfaction of its obligation under the June 2024 Agreement.

On December 17, 2024, the Company entered into an agreement with Magnus to purchase from Magnus an equal amount of its common stock as it purchases on the open market over the period of time from January 2, 2025 through June 30, 2025, up to an aggregate of $62.5 million, at the same weighted average per share price (the "December 2024 Agreement"). On July 10, 2025, the Company purchased 953,406 shares of its common stock from Magnus for an aggregate of $62.5 million in satisfaction of its obligation under the December 2024 Agreement.

The Company's share repurchase activity for the periods presented was as follows:

---

| | | |
|:---|:---|:---|
| | **Three months ended March 31,** | **Three months ended March 31,** |
| ***(in thousands, except share and per share amounts)*** | **2026** | **2025** |
| **Shares repurchased in the open market:** |  |  |
| Shares repurchased | 106008 | 540944 |
| Average price | $94.12 | $67.73 |
| Aggregate value <sup>(1)</sup> | $9977 | $36637 |
| **Total shares repurchased:** |  |  |
| Shares repurchased | 106008 | 540944 |
| Average price | $94.12 | $67.73 |
| Aggregate value | $9977 | $36637 |

---

___________________________________

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> Includes $1.0 million related to shares repurchased not settled as of the three months ended March 31, 2025.

17

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

As of March 31, 2026, the Company had $230.7 million remaining under the current share repurchase authorization.

**Common Stock Retirement**

The Company records retirements of repurchased common stock, upon either formal or constructive retirement, at cost and allocates the excess of the repurchase price over the par value of shares acquired to both retained earnings and additional paid-in capital. The portion allocated to additional paid-in capital is calculated on a pro rata basis of the shares to be retired and the total shares issued and outstanding as of the date of retirement. When shares of common stock are retired, they are deducted from the number of shares issued.

As of March 31, 2026, the Company presented as retired 106,008 shares of its repurchased common stock with an aggregate repurchase price of $10.0 million, which the Company intends to formally retire in 2026.

**11. Equity Incentive Plans**

Under the Acushnet Holdings Corp. Amended and Restated 2015 Omnibus Incentive Plan (the "Amended and Restated 2015 Plan"), the Company may grant stock options, stock appreciation rights, restricted shares of common stock, restricted stock units ("RSUs"), performance stock units ("PSUs") and other share-based and cash-based awards to members of the board of directors, officers, employees, consultants and advisors of the Company. As of March 31, 2026, the only equity-based awards granted under the Amended and Restated 2015 Plan were RSUs and PSUs.

As of March 31, 2026, there were 5,725,693 remaining shares of common stock reserved for issuance under the Amended and Restated 2015 Plan of which 3,120,170 remained available for future grants.

**Restricted Stock and Performance Stock Units**

RSUs granted to members of the board of directors vest immediately into shares of common stock. RSUs granted to the officers, employees, consultants and advisors of the Company vest in accordance with the terms of the grants, generally over three years, with one-third of each grant vesting annually, subject to the recipient's continued service to the Company. PSUs granted to Company officers and other employees vest based upon the Company's performance against specified targets, generally over a three-year performance period, subject to the recipient's continued service to the Company. At the end of the performance period, the number of shares of common stock that could be issued is determined based upon the Company's performance against these targets. The number of shares that could be issued can range from 0% to 200% of the recipient's target award. Recipients of the awards granted under the Amended and Restated 2015 Plan may elect to defer receipt of all or any portion of any shares of common stock issuable upon vesting to a future date elected by the recipient.

All RSUs and PSUs granted under the Amended and Restated 2015 Plan have DERs, which entitle holders of RSUs and PSUs to the same dividend value per share as holders of common stock and can be paid in either cash or common stock. DERs are subject to the same vesting and other terms and conditions as the corresponding RSUs and PSUs. DERs are paid when the underlying shares of common stock are delivered.

A summary of the Company's RSUs and PSUs as of March 31, 2026 and changes during the three months then ended is presented below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| |<br>**Number**<br>**of RSUs** | **Weighted-**<br>**Average**<br>**Fair Value RSUs** |<br>**Number**<br>**of PSUs** <sup>(3)</sup> | **Weighted-**<br>**Average**<br>**Fair Value PSUs** |
| **Outstanding as of December 31, 2025** | 603148 | $65.08 | 500371 | $60.05 |
| &nbsp;&nbsp;&nbsp;Granted | 219875 | 99.99 | 119704 | 100.01 |
| &nbsp;&nbsp;Vested <sup>(1)(2)</sup> | (306015) | 60.68 | (193351) | 48.21 |
| &nbsp;&nbsp;&nbsp;Forfeited | (515) | 67.73 |  |  |
| **Outstanding as of March 31, 2026** | 516493 | $82.55 | 426724 | $76.62 |

---

_______________________________________________________________________________

<sup>(1)</sup> Based upon the Company's level of achievement of the applicable performance metrics, the recipients of the 193,351 PSUs that vested during the three months ended March 31, 2026, were entitled to receive 241,882 shares of common stock.

<sup>(2)</sup> Included 26,195 and 67,041 shares of common stock related to RSUs and PSUs, respectively, that were not delivered as of March 31, 2026.

<sup>(3)</sup> Number of PSUs reflects 100% of the target level grant and may not be indicative of the performance level expected to be achieved.

18

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

Compensation expense recorded related to the Company's RSUs and PSUs in the unaudited condensed consolidated statements of operations was as follows:

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 31,** | **March 31,** |
| ***(in thousands)*** | **2026** | **2025** |
| RSUs | $4765 | $5032 |
| PSUs | 3815 | 1909 |

---

The remaining unrecognized compensation expense related to unvested RSUs and unvested PSUs was $38.9 million and $19.7 million, respectively, as of March 31, 2026, and is expected to be recognized over the related weighted average period of 1.6 years and 2.3 years, respectively.

A summary of shares of common stock issued related to the Amended and Restated 2015 Plan, including the impact of any DERs issued in common stock, is presented below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** |
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2025** | **March 31, 2025** |
| | **RSUs** | **PSUs** | **RSUs** | **PSUs** |
| Shares of common stock issued | 301045 | 177763 | 273390 | 121102 |
| Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations | (114664) | (81876) | (93949) | (53209) |
| Net shares of common stock issued | 186381 | 95887 | 179441 | 67893 |
| Cumulative undelivered shares of common stock | 515542 | 608574 | 517542 | 546789 |

---

**Compensation Expense**

The allocation of share-based compensation expense in the unaudited condensed consolidated statements of operations was as follows:

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 31,** | **March 31,** |
| ***(in thousands)*** | **2026** | **2025** |
| Cost of goods sold | $503 | $473 |
| Selling, general and administrative | 7635 | 6070 |
| Research and development | 442 | 398 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total compensation expense before income tax | 8580 | 6941 |
| Income tax benefit | 2099 | 1407 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total compensation expense, net of income tax | $6481 | $5534 |

---

**12. Accumulated Other Comprehensive Loss, Net of Tax**

Accumulated other comprehensive loss, net of tax consists of foreign currency translation adjustments, unrealized gains and losses from derivative instruments designated as cash flow hedges (Note 6) and pension and other postretirement adjustments (Note 8).

The components of and adjustments to accumulated other comprehensive loss, net of tax, were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(in thousands)*** |<br>**Foreign**<br>**Currency**<br>**Translation** | **Foreign**<br>**Exchange**<br>**Derivative**<br>**Instruments** |<br>**Pension and**<br>**Other**<br>**Postretirement** | **Accumulated**<br>**Other**<br>**Comprehensive**<br>**Loss, Net of Tax** |
| Balance as of December 31, 2025 | $(102533) | $485 | $(20233) | $(122281) |
| &nbsp;&nbsp;&nbsp;Other comprehensive (loss) income before reclassifications | (6298) | 2679 | 176 | (3443) |
| &nbsp;&nbsp;&nbsp;Amounts reclassified from accumulated other comprehensive loss, net of tax |  | 498 | 600 | 1098 |
| &nbsp;&nbsp;&nbsp;Tax expense |  | (794) | (183) | (977) |
| Balance as of March 31, 2026 | $(108831) | $2868 | $(19640) | $(125603) |

---

19

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

**13. Net Income per Common Share**

The following is a computation of basic and diluted net income per common share attributable to Acushnet Holdings Corp.:

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 31,** | **March 31,** |
| ***(in thousands, except share and per share amounts)*** | **2026** | **2025** |
| Net income attributable to Acushnet Holdings Corp. | $81416 | $99372 |
| Weighted average number of common shares: |  |  |
| &nbsp;&nbsp;&nbsp;Basic | 59845676 | 61325623 |
| &nbsp;&nbsp;&nbsp;&nbsp;RSUs | 163429 | 159165 |
| &nbsp;&nbsp;&nbsp;Diluted | 60009105 | 61484788 |
| Net income per common share attributable to Acushnet Holdings Corp.: |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $1.36 | $1.62 |
| &nbsp;&nbsp;&nbsp;Diluted | $1.36 | $1.62 |

---

Net income per common share attributable to Acushnet Holdings Corp. was calculated using the treasury stock method.

The Company's potential dilutive securities for the three months ended March 31, 2026 and 2025 include RSUs and PSUs. PSUs vest based upon achievement of performance targets and are excluded from the diluted shares outstanding unless the performance targets have been met as of the end of the applicable reporting period regardless of whether such performance targets are probable of achievement.

The following securities have been excluded from the calculation of diluted weighted-average common shares outstanding as their impact was determined to be anti-dilutive:

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 31,** | **March 31,** |
| | **2026** | **2025** |
| RSUs | 168,464 | 248,808 |

---

**14. Segment Information**

The Company's operating segments are based on how the Chief Operating Decision Maker ("CODM"), the Company's President and Chief Executive Officer, makes decisions about assessing performance and allocating resources. The Company currently has three reportable segments: (i) Titleist golf equipment, (ii) FootJoy golf wear and (iii) Golf gear.

The CODM primarily uses segment operating income (loss) to evaluate the effectiveness of business strategies, assess segment operating performance and make decisions regarding costs to incur across the business. Segment operating income (loss) includes directly attributable expenses and certain shared costs of corporate administration that are allocated to the operating segments, but excludes certain other costs, such as interest expense, net; restructuring costs; the non-service cost component of net periodic benefit cost; transaction fees; as well as other items that are not allocated to the operating segments. The CODM does not evaluate a measure of assets when assessing performance.

Results shown for the three months ended March 31, 2026 and 2025 are not necessarily those which would be achieved if each segment was an unaffiliated business enterprise. There are no material intersegment transactions.

20

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

Information by reportable segment and a reconciliation to reported amounts are as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** |
| ***(in thousands)*** | **Titleist Golf Equipment** | **FootJoy Golf Wear** | **Golf Gear** | **Total Reportable Segments** | **Other** <sup>(1)</sup> | **Total Consolidated** |
| Net sales | $458503 | $181532 | $78730 | $718765 | $34210 | $752975 |
| Segment expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;Cost of goods sold | 226196 | 110158 | 45760 | 382114 |  |  |
| &nbsp;&nbsp;Advertising and promotion | 48489 | 13158 | 3431 | 65078 |  |  |
| &nbsp;&nbsp;Research and development | 16715 | 1257 | 771 | 18743 |  |  |
| &nbsp;&nbsp;Selling, general and administrative | 81695 | 35923 | 12287 | 129905 |  |  |
| &nbsp;&nbsp;Other segment items <sup>(2)</sup> | 1215 | 56 | 649 | 1920 |  |  |
| Other expenses |  |  |  |  | 35066 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating income | 84193 | 20980 | 15832 | 121005 | (856) | 120149 |
| Reconciling items: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest expense, net |  |  |  |  |  | (13072) |
| &nbsp;&nbsp;&nbsp;Non-service cost component of net periodic benefit cost |  |  |  |  |  | (1570) |
| &nbsp;&nbsp;&nbsp;Other |  |  |  |  |  | (246) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total income before income tax |  |  |  |  |  | $105261 |

---

<sup>_________________________________</sup>

<sup>(1)</sup> Amounts represent operating segments that do not meet the quantitative thresholds to be a reportable segment, as well as unallocated corporate expenses. These non-reportable segments include two premium performance apparel businesses.

<sup>(2)</sup> Other segment items primarily include identifiable intangible asset amortization expense.

Information by reportable segment and a reconciliation to reported amounts are as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** |
| ***(in thousands)*** | **Titleist Golf Equipment** | **FootJoy Golf Wear** | **Golf Gear** | **Total Reportable Segments** | **Other** <sup>(1)</sup> | **Total Consolidated** |
| Net sales | $421092 | $178436 | $70963 | $670491 | $32881 | $703372 |
| Segment expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;Cost of goods sold | 206524 | 104232 | 40824 | 351580 |  |  |
| &nbsp;&nbsp;Advertising and promotion | 44659 | 13397 | 3401 | 61457 |  |  |
| &nbsp;&nbsp;Research and development | 16344 | 1310 | 675 | 18329 |  |  |
| &nbsp;&nbsp;Selling, general and administrative | 75269 | 34927 | 11649 | 121845 |  |  |
| &nbsp;&nbsp;Other segment items <sup>(2)</sup> | 2448 | 55 | 648 | 3151 |  |  |
| Other expenses |  |  |  |  | 32463 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating income | 75848 | 24515 | 13766 | 114129 | 418 | 114547 |
| Reconciling items: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest expense, net |  |  |  |  |  | (13815) |
| &nbsp;&nbsp;&nbsp;Non-service cost component of net periodic benefit cost |  |  |  |  |  | (869) |
| &nbsp;&nbsp;Other <sup>(3)</sup> |  |  |  |  |  | 20732 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total income before income tax |  |  |  |  |  | $120595 |

---

<sup>_________________________________</sup>

<sup>(1)</sup> Amounts represent operating segments that do not meet the quantitative thresholds to be a reportable segment, as well as unallocated corporate expenses. These non-reportable segments include two premium performance apparel businesses.

<sup>(2)</sup> Other segment items primarily include identifiable intangible asset amortization expense.

<sup>(3)</sup> Other includes a non-cash gain on deconsolidation of VIE of $20.9 million (Note 16).

21

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

Information as to the Company's operations in different geographic regions is presented below. Net sales are categorized based on the location in which the sale originates.

---

| | | |
|:---|:---|:---|
| | **Three months ended March 31,** | **Three months ended March 31,** |
| ***(in thousands)*** | **2026** | **2025** |
| United States | $445161 | $424209 |
| EMEA <sup>(1)</sup> | 124387 | 103869 |
| Japan | 36406 | 35232 |
| Korea | 61170 | 66218 |
| Rest of World | 85851 | 73844 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total net sales** | $752975 | $703372 |

---

_______________________________________________________________________________

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> Europe, the Middle East and Africa ("EMEA")

**15. Commitments and Contingencies**

**Litigation**

The Company and its subsidiaries are party to various legal proceedings associated with the normal conduct of their businesses and operations. When a loss related to a legal proceeding is probable and reasonably estimable, the Company accrues its best estimate for the ultimate resolution of the matter. While it is not possible to predict the outcome of any of these matters, the Company does not believe any currently pending legal matters will have a material adverse impact on the Company's results of operations, financial position or cash flows. Actual outcomes may differ from those expected and could have a material effect on the Company's financial position, results of operations or cash flows in a future period.

**Other Matters**

In February 2026, the U.S. Supreme Court ruled that certain tariffs under the International Emergency Economic Powers Act ("IEEPA") were invalid, and in March 2026, the U.S. Court of International Trade issued an order directing U.S. Customs and Border Protection ("CBP") to refund duties imposed under IEEPA. In April 2026, CBP established a refund portal, allowing importers of record and authorized customs brokers to submit refund requests. The situation continues to evolve, and further legislative, regulatory, or judicial developments may affect the ultimate outcome and the availability or timing of any refunds. As of the reporting date, the Company has not recognized an asset related to any potential refunds that may be received in relation to requests that the Company has submitted. The Company will continue to evaluate new information and will recognize refunds in its financial statements when the requirements of accounting for gain contingencies under Accounting Standards Codification 450, "Contingencies", have been met.

22

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

**16. Other Business Developments**

**Investment in Less than Wholly-Owned Subsidiary**

During the three months ended March 31, 2026, the Company invested an additional $6.4 million in ACTPI, LLC, a less than wholly-owned subsidiary ("ACTPI"), increasing the Company's ownership interest from 80% to 84.3%. ACTPI was formed in connection with the November 4, 2022, acquisition of an 80% interest in certain assets and liabilities of TPI EDU, LLC, Onbase University, LP and Racquetfit, LP for cash consideration of $18.4 million. ACTPI educates golfers and industry professionals on the body-swing connection through its 'TPI Certified' program.

**Supply Chain Optimization** 

Prior to January 31, 2025, the Company consolidated the accounts of its FootJoy manufacturing joint venture, Acushnet Lionscore Limited ("Lionscore"), a VIE which is 40% owned by the Company. During January 2025, Lionscore permanently ceased manufacturing at its Fujian Fuh Deh Leh ("FDL") factory in Fuzhou, China and all footwear production volume was shifted to a third-party facility located in Long An Province, Vietnam (the "Long An Factory"), which is operated by an affiliate of Myre Overseas Corp. ("Myre"), the Company's Lionscore joint venture partner. As a result, the Company is no longer the primary beneficiary of Lionscore and has deconsolidated the accounts of Lionscore effective as of January 31, 2025. As such, the unaudited condensed consolidated statement of operations for the three months ended March 31, 2025 included one month of activity related to Lionscore prior to the deconsolidation. The fair value of the Company's equity interest in Lionscore as of the date of deconsolidation, determined by the appraised value of Lionscore's operating assets, was $14.1 million. In connection with the deconsolidation of Lionscore, the Company recorded a non-cash gain on deconsolidation of $20.9 million during the three months ended March 31, 2025, which was included within other expense (income), net on the unaudited condensed consolidated statement of operations. Subsequent to the deconsolidation, the Company accounts for its equity ownership interest in Lionscore under the equity method of accounting.

For the three months ended March 31, 2026 and 2025, the Company recorded a $0.1 million and $0.2 million loss respectively, related to the Lionscore equity-method investment, which was included within other expense (income), net on the unaudited condensed consolidated statements of operations. The carrying value of the Company's investment in Lionscore was $12.9 million and $13.0 million as of March 31, 2026 and December 31, 2025, respectively, which was included within other assets on the unaudited condensed consolidated balance sheets.

On January 6, 2026, Acushnet Cayman Limited, a wholly owned subsidiary of the Company ("Acushnet Cayman"), entered into a Subscription and Shareholders' Agreement (the "JV Agreement") with Myre and ACL FootJoy Pte. Ltd. ("ACL FootJoy"), pursuant to which Acushnet Cayman and Myre formed a joint venture and subscribed for shares in the capital of ACL FootJoy. The primary purpose of ACL FootJoy, in which the Company has a 40% interest with the remaining 60% owned by Myre, is to source raw materials for, and contract for the manufacture and production of, footwear in Vietnam, under trademarks and brand names owned by Acushnet Company ("Products") at one or more factories owned and/or controlled by Myre and/or its affiliates (the "Footwear Factories"), including the Long An Factory. Pursuant to the JV Agreement, the Company has the sole and exclusive right to purchase and distribute, and to arrange for the worldwide sale and distribution of, all Products manufactured or produced at the Footwear Factories. The Company was deemed to be the primary beneficiary due to its controlling financial interest in ACL FootJoy and as such, the Company consolidated ACL FootJoy as a VIE.

On January 28, 2026, ACL FootJoy entered into a promissory note with Lionscore, allowing ACL FootJoy to borrow up to $9.0 million to support working capital needs. The promissory note is non-interest bearing with a maturity date of January 28, 2029. As of March 31, 2026, outstanding borrowings under the promissory note of $1.5 million were included in other noncurrent liabilities on the Company's unaudited condensed consolidated balance sheet. To the extent ACL FootJoy's capital needs exceed its resources, additional funding may be provided by the Company in the form of equity or loans, however the Company is not legally obligated to provide such funding. Other than the promissory note, ACL FootJoy has no other outstanding borrowings.

**PG Golf**

On April 1, 2022, the Company acquired the outstanding equity interest in PG Golf LLC for $5.0 million, including cash consideration of $3.6 million and contingent consideration valued at $1.4 million at the time of acquisition. As of March 31, 2025, contingent consideration of $1.7 million was included in accrued expenses and other liabilities on the unaudited condensed consolidated balance sheet and was subsequently paid in April 2025.

23

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

**17. Restructuring Costs**

**Voluntary Bridge to Retirement**

During the second quarter of 2025, the Company initiated a VBR program to reduce operating costs and bridge certain long-tenured eligible employees to retirement. As part of this program, eligible employees were offered severance in the form of salary and benefit continuation.

The activity related to the VBR program was as follows:

---

| | |
|:---|:---|
| ***(in thousands)*** | **Three months ended March 31, 2026** |
| **Balance at beginning of period** | $9855 |
| Decrease in provision for expected restructuring costs | (114) |
| Payments | (3498) |
| **Balance at end of period** | $6243 |

---

The provision for costs associated with the VBR program was included in selling, general and administrative on the unaudited condensed consolidated statement of operations. The total costs associated with the VBR program were $13.6 million. There are no further material costs expected to be incurred in relation to the VBR program. Payments are expected to continue through the first half of 2027.

The VBR program liabilities recognized on the unaudited condensed consolidated balance sheets were as follows:

---

| | | |
|:---|:---|:---|
| ***(in thousands)*** | | |
| **Balance Sheet Location** | **March 31,**<br>**2026** | **December 31,**<br>**2025** |
| Accrued expenses and other liabilities | $5890 | $9033 |
| Other noncurrent liabilities | 353 | 822 |

---

**Lionscore**

In 2024, Lionscore approved a plan to permanently cease manufacturing at its FDL factory and shift all footwear production volume to the Long An Factory. As a result, substantially all FDL factory employees had been involuntary separated by the first quarter of 2025.

The activity related to this plan was as follows:

---

| | |
|:---|:---|
| ***(in thousands)*** | **Three months ended March 31, 2025** |
| **Balance at beginning of period** | $12431 |
| Payments | (5439) |
| Deconsolidation of VIE (Note 16) | (6992) |
| **Balance at end of period** | $— |

---

The total employee termination costs associated with this plan was $18.0 million. There are no further costs expected to be incurred in relation to these restructuring plans. See Note 16 for further information.

24

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

***ITEM 2.****&nbsp;&nbsp;&nbsp;&nbsp;* ***MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS***

*The following discussion contains management's discussion and analysis of our financial condition and results of operations and should be read together with our unaudited condensed consolidated financial statements and the notes thereto included elsewhere in this Quarterly Report on Form 10-Q. This discussion contains forward-looking statements that reflect our plans, estimates and beliefs and involve numerous risks and uncertainties, including but not limited to those described in "Part II, Item 1A. Risk Factors" and elsewhere in this Quarterly Report on Form 10-Q and in our other filings with the Securities and Exchange Commission. Actual results may differ materially from those contained in any forward-looking statements. You should carefully read "Special Note Regarding Forward-Looking Statements" following the **Table of Contents**. Unless otherwise noted, the figures in the following discussion are unaudited.*

**Overview**

We are the global leader in the design, development, manufacture and distribution of performance-driven golf products, and these products are widely recognized for their quality excellence. Today, we are the steward of two of the most revered brands in golf—Titleist, one of golf's leading performance equipment brands, and FootJoy, one of golf's leading performance wearable brands.

Our target market is dedicated golfers, who are the cornerstone of the worldwide golf industry. These dedicated golfers are avid and skill-biased, prioritize performance and commit the time, effort and money to improve their game. We believe our focus on innovation and process excellence yields golf products that represent superior performance and consistent product quality, which are the key attributes sought after by dedicated golfers. Many of the game's professional players, who represent the most dedicated golfers, prefer our products, thereby validating our performance and quality promise while also driving brand awareness. We seek to leverage a pyramid of influence product and promotion strategy, whereby our products are the most played by the world's best players, creating aspirational appeal for a broad range of golfers who want to emulate the performance of the game's best players.

We believe our differentiated focus on performance and quality excellence, enduring connections with dedicated golfers and favorable and market-differentiating mix of consumable and durable products have been the key drivers of our financial performance.

Our net sales are diversified by both product category and mix, as well as geography. Our product categories include golf balls, golf clubs, wedges and putters, golf shoes, golf gloves, golf gear, and golf and ski outerwear and apparel. Our product portfolio contains a favorable mix of consumable products, which we consider to be golf balls and golf gloves, and more durable products, which we consider to be golf clubs, golf shoes, golf gear, and golf and ski outerwear and apparel. Our net sales are also diversified by geography, with a substantial majority of our net sales generated in five countries: the United States, Japan, Korea, the United Kingdom, and Canada. We have three reportable segments: Titleist golf equipment, FootJoy golf wear, and Golf gear.

*Recent Developments* 

<u>Geopolitical Developments and Macroeconomic Factors</u>: The global economy continues to experience elevated levels of volatility and uncertainty, including within the commodity markets, driven by a combination of geopolitical developments and macroeconomic factors. Increased U.S. tariffs have led and may continue to lead to the imposition of retaliatory tariffs by foreign jurisdictions, which have further contributed to disruptions in global capital markets and global supply chains. As a result, we have incurred and may continue to incur incremental costs in connection with importing raw materials, component parts and finished goods. We have implemented various strategies to mitigate the effect of these incremental costs on our gross profit and gross margin.

In February 2026, the U.S. Supreme Court ruled that certain tariffs under the International Emergency Economic Powers Act ("IEEPA") were invalid, and in March 2026, the U.S. Court of International Trade issued an order directing U.S. Customs and Border Protection ("CBP") to refund duties imposed under IEEPA. In April 2026, CBP established a refund portal, allowing importers of record and authorized customs brokers to submit refund requests. The situation continues to evolve, and further legislative, regulatory, or judicial developments may affect the ultimate outcome and the availability or timing of any refunds. Our results of operations for the three months ended March 31, 2026 do not include the impact of any potential refunds that we may receive.

Current uncertainties around geopolitical developments and macroeconomic factors and their effects on trading relationships may further affect the costs of our imported raw materials, components parts and finished goods, as well as

25

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

increase market volatility and currency exchange rate fluctuations, which may influence our hedging strategy. In addition, these factors, and any changes to these factors, could have a material adverse effect on consumer behavior and on our future revenues and overall profitability. We continue to monitor the economic effects of these developments and evaluate opportunities to mitigate their related impacts.

<u>Supply Chain Optimization</u>: On January 6, 2026, we formed a new joint venture with Myre and subscribed for shares in the capital of ACL FootJoy, in which we have a 40% interest, with the remaining 60% owned by Myre. The primary purpose of ACL FootJoy is to source raw materials for, and contract for the manufacture and production of, footwear in Vietnam, at one or more factories owned and/or controlled by Myre and/or its affiliates. We currently contract to manufacture substantially all of our FootJoy footwear at the Long An Factory pursuant to this joint venture arrangement. See "Notes to Unaudited Condensed Consolidated Financial Statements – Note 16 – Other Business Developments," Item 1 of Part I to this report.

<u>Information Technology Optimization</u>: During 2024, we began a multi-year implementation of a new global cloud-based enterprise resource planning ("ERP") platform as part of our plans to integrate our operations and enhance our supply chain and finance capabilities. We expect that the new global ERP platform will enable further operating efficiencies and support the Company's digital transformation. Additional implementation activities are expected to continue in phases by geographic region over the next several years. The global ERP platform implementation spending comprises both capitalized costs and operating expenses. The operating expenses represent costs directly related to the deployment of the global ERP platform above the normal ongoing level of spending on information technology to support our operations. In connection with this strategic initiative, during the three months ended March 31, 2026 and 2025, we incurred expenses of $3.0 million and $2.6 million, respectively. In addition, we invested $5.7 million and $8.0 million for capitalized implementation costs associated with the integration, configuration and customization of this new global ERP platform during the three months ended March 31, 2026 and 2025, respectively. We anticipate spending approximately $30 million to $35 million in total for the full year related to the deployment of the new global ERP platform.

**Key Performance Measures**

We use various financial metrics to measure and evaluate our business, including, among others: (i) net sales on a constant currency basis, (ii) Adjusted EBITDA on a consolidated basis, (iii) Adjusted EBITDA margin on a consolidated basis and (iv) segment operating income (loss).

Since a significant percentage of our net sales are generated outside of the United States, we use net sales on a constant currency basis to evaluate the sales performance of our business in period over period comparisons and to forecast our business going forward. Constant currency information allows us to estimate what our sales performance would have been without changes in foreign currency exchange rates. This information is calculated by taking the current period local currency net sales and translating them into U.S. dollars based upon the foreign currency exchange rates for the applicable comparable prior period. This constant currency information should not be considered in isolation or as a substitute for any measure derived in accordance with U.S. GAAP. Our presentation of constant currency information may not be consistent with the manner in which similar measures are derived or used by other companies.

We primarily use Adjusted EBITDA on a consolidated basis to evaluate the effectiveness of our business strategies, assess our consolidated operating performance and make decisions regarding the pricing of our products, go-to-market execution and costs to incur across our business. We present Adjusted EBITDA as a supplemental measure of our operating performance because it excludes the impact of certain items that we do not consider indicative of our ongoing operating performance. We define "Adjusted EBITDA" in a manner consistent with the term "Consolidated EBITDA" as it is defined in our credit agreement. Adjusted EBITDA represents net income (loss) attributable to Acushnet Holdings Corp. plus interest expense, net, income tax expense (benefit), depreciation and amortization, and other items defined in our credit agreement, including: share-based compensation expense; restructuring and transformation costs; certain transaction fees; extraordinary, unusual or nonrecurring losses or charges; indemnification expense (income); certain pension settlement costs; certain other non-cash (gains) losses, net and the net income (loss) relating to noncontrolling interests. Adjusted EBITDA is not a measurement of financial performance under U.S. GAAP. It should not be considered an alternative to net income (loss) attributable to Acushnet Holdings Corp. as a measure of our operating performance or any other measure of performance derived in accordance with U.S. GAAP. In addition, Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items, or affected by similar nonrecurring items. Adjusted EBITDA has limitations as an analytical tool, and you should not consider such measure either in isolation or as a substitute for analyzing our results as reported under U.S. GAAP. Our definition and calculation of Adjusted EBITDA is not necessarily comparable to other similarly titled measures used by other companies due to different methods of calculation. For a reconciliation of Adjusted EBITDA to net income (loss) attributable to Acushnet Holdings Corp., see "—Results of Operations" below.

26

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

We also use Adjusted EBITDA margin on a consolidated basis, which measures our Adjusted EBITDA as a percentage of net sales, because our management uses it to evaluate the effectiveness of our business strategies, assess our consolidated operating performance and make decisions regarding pricing of our products, go-to-market execution and costs to incur across our business. We present Adjusted EBITDA margin as a supplemental measure of our operating performance because it excludes the impact of certain items that we do not consider indicative of our ongoing operating performance. Adjusted EBITDA margin is not a measurement of financial performance under U.S. GAAP. It should not be considered an alternative to any measure of performance derived in accordance with U.S. GAAP. In addition, Adjusted EBITDA margin should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items, or affected by similar nonrecurring items. Adjusted EBITDA margin has limitations as an analytical tool, and you should not consider such measure either in isolation or as a substitute for analyzing our results as reported under U.S. GAAP. Our definition and calculation of Adjusted EBITDA margin is not necessarily comparable to other similarly titled measures used by other companies due to different methods of calculation.

Lastly, we use segment operating income (loss) to evaluate the effectiveness of business strategies, assess segment operating performance and make decisions regarding costs to incur across the business. Segment operating income (loss) includes directly attributable expenses and certain shared costs of corporate administration that are allocated to the operating segments, but excludes certain other costs, such as interest expense, net; restructuring costs; the non-service cost component of net periodic benefit cost; transaction fees; as well as other items that are not allocated to the operating segments.

27

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

 **Results of Operations**

The following table sets forth, for the periods indicated, our results of operations.

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 31,** | **March 31,** |
| ***(in thousands)*** | **2026** | **2025** |
| Net sales | $752975 | $703372 |
| Cost of goods sold | 397715 | 366210 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 355260 | 337162 |
| Operating expenses: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative | 213671 | 200261 |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development | 19195 | 18859 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intangible amortization | 2245 | 3495 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income from operations | 120149 | 114547 |
| Interest expense, net | 13072 | 13815 |
| Other expense (income), net | 1816 | (19863) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income before income taxes | 105261 | 120595 |
| Income tax expense | 24101 | 21570 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | 81160 | 99025 |
| Less: Net loss attributable to noncontrolling interests | 256 | 347 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to Acushnet Holdings Corp. | $81416 | $99372 |
| **Adjusted EBITDA:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to Acushnet Holdings Corp. | $81416 | $99372 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | 13072 | 13815 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense | 24101 | 21570 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 12869 | 14277 |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | 8580 | 6941 |
| &nbsp;&nbsp;&nbsp;&nbsp;Transformation costs <sup>(1)</sup> | 3062 | 3158 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other <sup>(2)</sup> | 1717 | (19930) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss attributable to noncontrolling interests | (256) | (347) |
| Adjusted EBITDA | $144561 | $138856 |
| Adjusted EBITDA margin | 19.2% | 19.7% |

---

________________________

<sup>(1)</sup> For the three months ended March 31, 2026 and 2025, includes $3.0 million and $2.6 million, respectively, related to our information technology optimization.

<sup>(2)</sup> For the three months ended March 31, 2026 and 2025, includes $0.5 million and $0.8 million, respectively, related to the amortization of capitalized implementation costs for cloud computing arrangements. For the three months ended March 31, 2025, includes a non-cash gain of $20.9 million related to the deconsolidation of Lionscore. The three months ended March 31, 2026 and 2025 also include other gains, losses or costs added back for purposes of calculating Adjusted EBITDA as defined in our credit agreement.

28

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

***Three Months Ended March 31, 2026 Compared to the Three Months Ended March 31, 2025***

Net sales by reportable segment is summarized as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | | | **Constant Currency** | **Constant Currency** |
| | **March 31,** | **March 31,** | **Increase/(Decrease)** | **Increase/(Decrease)** | **Increase/(Decrease)** | **Increase/(Decrease)** |
| **(in millions)** | **2026** | **2025** | **$ change** | **% change** | **$ change** | **% change** |
| &nbsp;&nbsp;Golf balls | $234.5 | $213.3 | $21.2 | 9.9% | $17.5 | 8.2% |
| &nbsp;&nbsp;Golf clubs | 224.0 | 207.8 | 16.2 | 7.8% | 12.3 | 5.9% |
| Titleist golf equipment | 458.5 | 421.1 | 37.4 | 8.9% | 29.8 | 7.1% |
| FootJoy golf wear | 181.5 | 178.4 | 3.1 | 1.7% | (2.4) | (1.3)% |
| Golf gear | 78.7 | 71.0 | 7.7 | 10.8% | 5.9 | 8.3% |

---

Net sales information by region is summarized as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | | | **Constant Currency** | **Constant Currency** |
| | **March 31,** | **March 31,** | **Increase/(Decrease)** | **Increase/(Decrease)** | **Increase/(Decrease)** | **Increase/(Decrease)** |
| **(in millions)** | **2026** | **2025** | **$ change** | **% change** | **$ change** | **% change** |
| United States | $445.2 | $424.2 | $21.0 | 5.0% | $21.0 | 5.0% |
| EMEA <sup>(1)</sup> | 124.4 | 103.9 | 20.5 | 19.7% | 8.3 | 8.0% |
| Japan | 36.4 | 35.2 | 1.2 | 3.4% | 2.1 | 6.0% |
| Korea | 61.2 | 66.2 | (5.0) | (7.6)% | (4.6) | (6.9)% |
| Rest of World | 85.8 | 73.9 | 11.9 | 16.1% | 6.8 | 9.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total net sales | $753.0 | $703.4 | $49.6 | 7.1% | $33.6 | 4.8% |

---

_______________________________________________________________________________

<sup>(1)</sup> Europe, the Middle East and Africa ("EMEA")

Segment operating income by reportable segment is summarized as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | | |
| **(in millions)** | **March 31,** | **March 31,** | **Increase/(Decrease)** | **Increase/(Decrease)** |
| **Segment operating income** | **2026** | **2025** | **$ change** | **% change** |
| Titleist golf equipment | $84.2 | $75.8 | $8.4 | 11.1% |
| FootJoy golf wear | 21.0 | 24.5 | (3.5) | (14.3)% |
| Golf gear | 15.8 | 13.8 | 2.0 | 14.5% |

---

*Net Sales*

For the three months ended March 31, 2026, net sales increased 7.1%, or 4.8% on a constant currency basis, compared to the three months ended March 31, 2025. The increase was driven by higher net sales in Titleist golf equipment, primarily due to higher sales volumes in golf clubs and golf balls, and higher average selling prices in golf balls, as well as higher net sales in Golf gear, primarily due to higher average selling prices across all product categories. These increases were partially offset by lower net sales, on a constant currency basis, in FootJoy golf wear, primarily due to lower sales volumes in footwear, partially offset by higher average selling prices across all product categories.

The increase in net sales in the United States was primarily driven by increases in Titleist golf equipment of $17.9 million and in Golf gear of $4.7 million, partially offset by a decrease in FootJoy golf wear of $2.4 million. The increase in Titleist golf equipment was primarily driven by higher average selling prices of our Pro V1 golf ball models, as well as higher sales volumes of our newly introduced SM11 wedges, latest generation T-Series irons, and performance model golf balls, partially offset by lower sales volumes of our second model year hybrids, drivers, fairways, and Scotty Cameron putters. The increase in Golf gear was primarily driven by higher average selling prices across all product categories and higher sales volumes in golf bags. The decrease in FootJoy golf wear was primarily due to lower sales volumes, partially offset by higher average selling prices in apparel.

Net sales in regions outside the United States increased 10.2%, or 4.5% on a constant currency basis, driven by increases in EMEA, Rest of World and Japan, partially offset by a decrease in Korea. In EMEA and Rest of World, the

29

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

increases were primarily driven by higher net sales across all reportable segments. In Japan, the increase was driven by higher net sales in Titleist golf equipment, mainly golf clubs. In Korea, the decrease was primarily due to lower net sales in all reportable segments, as well as products that are not allocated to one of our three reportable segments.

*Gross Profit*

Gross profit increased $18.1 million for the three months ended March 31, 2026 compared to the three months ended March 31, 2025. Gross margin was 47.2% for the three months ended March 31, 2026 compared to 47.9% for the three months ended March 31, 2025. The increase in gross profit was primarily the result of increases in Titleist golf equipment of $17.7 million and Golf gear of $2.8 million. The increase in Titleist golf equipment was primarily due to the higher sales volumes and higher average selling prices discussed previously. The increase in Golf gear was primarily driven by the higher average selling prices discussed previously. These increases in gross profit also include the impact of higher tariff costs due to the tariff measures discussed previously. These increases were partially offset by a decrease in FootJoy golf wear of $2.8 million, primarily due to the higher tariff costs, partially offset by the higher average selling prices discussed previously.

*Selling, General and Administrative Expenses*

SG&A expenses increased $13.4 million for the three months ended March 31, 2026 compared to the three months ended March 31, 2025. This increase was primarily the result of increases of $4.7 million in selling expense, $4.1 million in administrative expense, and $3.4 million in advertising and promotion expenses. The increase in selling expense was primarily due to higher employee related expenses incurred in connection with the sales volume increases discussed previously, and investments to expand our product fitting networks and to enhance consumer engagement. The increase in administrative expense was primarily due to higher information technology-related expenses. The increase in advertising and promotion expenses was primarily in Titleist golf equipment to support new product launches. SG&A expenses also include a $3.2 million increase in foreign currency transaction losses, offset in part by a $1.8 million increase in gains on foreign exchange forward contracts.

*Intangible amortization*

Intangible amortization expense decreased $1.3 million for the three months ended March 31, 2026 compared to the three months ended March 31, 2025 due to certain intangible assets becoming fully amortized during the prior period.

*Other Expense (Income), net*

Other expense, net increased $21.7 million for the three months ended March 31, 2026 compared to other income, net of $19.9 million for the three months ended March 31, 2025, primarily due to a non-cash gain of $20.9 million recognized in the prior year period related to the deconsolidation of Lionscore.

*Income Tax Expense*

Income tax expense increased $2.5 million for the three months ended March 31, 2026 compared to the three months ended March 31, 2025. Our ETR was 22.9% for the three months ended March 31, 2026 compared to 17.9% for the three months ended March 31, 2025. The change in ETR was primarily driven by changes in our jurisdictional mix of earnings, as well as a reduced income tax benefit related to the U.S. deduction of foreign-derived intangible income.

30

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

*Segment Results*

**Titleist Golf Equipment Segment**

Net sales in our Titleist golf equipment segment increased 8.9%, or 7.1% on a constant currency basis, for the three months ended March 31, 2026 compared to the three months ended March 31, 2025, primarily driven by higher sales volumes of our recently launched SM11 wedges and latest generation T-Series irons, higher average selling prices of our Pro V1 golf ball models and higher sales volumes of our recently launched AVX, Tour Soft and Velocity performance golf ball models, partially offset by lower sales volumes of our second model year hybrids, drivers, fairways, and Scotty Cameron putters.

Operating income in our Titleist golf equipment segment increased $8.4 million, or 11.1% compared to the prior year period. The increase in operating income resulted from higher gross profit of $17.7 million, partially offset by higher operating expenses of $9.4 million. The increase in gross profit was primarily driven by the higher sales volumes and higher average selling prices as discussed previously, partially offset by higher tariff costs. Higher operating expenses were a result of increases of $3.8 million in advertising and promotion expenses, $3.3 million in selling expense, and $3.1 million in administrative expense. These increases were partially offset by a decrease of $1.2 million in amortization expense, as discussed previously.

**FootJoy Golf Wear Segment**

Net sales in our FootJoy golf wear segment increased 1.7%, or decreased 1.3% on a constant currency basis, for the three months ended March 31, 2026 compared to the three months ended March 31, 2025. On a constant currency basis net sales decreased largely due to lower sales volumes in footwear, partially offset by higher average selling prices across all product categories.

Operating income in our FootJoy golf wear segment decreased $3.5 million, or 14.3% compared to the prior year period. The decrease in operating income resulted from lower gross profit of $2.8 million and higher operating expenses of $0.7 million. Gross profit decreased primarily as a result of higher tariff costs, partially offset by the higher average selling prices discussed previously.

**Golf Gear Segment**

Net sales in our Golf gear segment increased 10.8%, or 8.3% on a constant currency basis, for the three months ended March 31, 2026 compared to the three months ended March 31, 2025, primarily driven by higher average selling prices across all product categories, as well as higher sales volumes in golf bags, partially offset by lower sales volumes in the travel product category.

Operating income in our Golf gear segment increased $2.0 million, or 14.5% compared to the prior year period. The increase in operating income resulted from higher gross profit of $2.8 million, partially offset by higher operating expenses of $0.8 million. The increase in gross profit was largely due to the higher average selling prices, partially offset by higher tariff costs.

**Liquidity and Capital Resources**

Our primary cash needs relate to working capital, repurchasing shares of our common stock, capital expenditures, paying dividends, servicing our debt and pension contributions. Additionally, from time to time, we may make strategic investments to complement our products, technologies or businesses, which could impact our liquidity needs. We expect to rely on cash flows from operations and borrowings under our multi-currency revolving credit facility and local credit facilities as our primary sources of liquidity.

Our liquidity is impacted by our level of working capital, which is cyclical as a result of the general seasonality of our business. Our accounts receivable balance is generally at its highest starting at the end of the first quarter and continuing through the second quarter, and declines during the third and fourth quarters as a result of both an increase in cash collections and lower sales. Our inventory balance also fluctuates as a result of the seasonality of our business. Generally, our buildup of inventory starts during the fourth quarter and continues through the first quarter and into the beginning of the second quarter in order to meet demand for our initial sell-in during the first quarter and reorders in the second quarter. Both accounts receivable and inventory balances are impacted by the timing of new product launches.

As of March 31, 2026, we had $50.4 million of unrestricted cash and cash equivalents (including $0.9 million attributable to ACL FootJoy, a VIE). As of March 31, 2026, 94.7% of our total unrestricted cash and cash equivalents was held by subsidiaries in regions outside of the United States, including ACL FootJoy. We manage our worldwide cash requirements

31

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

by monitoring the funds available among our subsidiaries and determining the extent to which we can access those funds on a cost-effective basis. We are not aware of any restrictions on repatriation of these funds and, subject to foreign withholding taxes, those funds could be repatriated, if necessary. We have repatriated, and intend to repatriate, funds to the United States from time to time to satisfy domestic liquidity needs arising in the ordinary course of business.

Macroeconomic factors, including those discussed in Recent Developments above, could impact our results of operations in ways we cannot currently predict. Nonetheless, we believe that cash expected to be provided by operating activities, together with our cash on hand and the availability of borrowings under our multi-currency revolving credit facility and our local credit facilities (subject to customary borrowing conditions) will be sufficient to meet our liquidity requirements for at least the next 12 months. Our ability to generate sufficient cash flows from operations is, however, subject to many risks and uncertainties, including current and future economic trends and conditions, demand for our products, availability and cost of our raw materials and components, foreign currency exchange rates and other risks and uncertainties applicable to our business, as described in our Annual Report on Form 10-K for the year ended December 31, 2025.

**Debt and Financing Arrangements**

As of March 31, 2026, we had $318.4 million of available borrowing capacity under our multi-currency revolving credit facility after giving effect to $4.0 million of outstanding letters of credit. Additionally, we had $24.8 million available borrowing capacity under certain local credit facilities of our subsidiaries.

The credit agreement governing our multi-currency revolving credit facility contains customary affirmative and restrictive covenants, including, among others, financial covenants based on our leverage and interest coverage ratios. This credit agreement also includes customary events of default, the occurrence of which, following any applicable cure period, would permit the lenders to, among other things, declare the principal, accrued interest and other obligations to be immediately due and payable. As of March 31, 2026, we were in compliance with all covenants under our credit agreement.

The indenture that governs the Notes (the "Indenture") contains covenants that, among other things, limit the ability of the Company and its subsidiaries to incur liens securing indebtedness for borrowed money, enter into sale and leaseback transactions, and consolidate or merge with or into other companies. As of March 31, 2026, we were in compliance with all covenants under the Indenture.

See "Notes to Unaudited Condensed Consolidated Financial Statements – Note 5 – Debt and Financing Arrangements," Item 1 of Part I to this report and "Notes to Consolidated Financial Statements – Note 11 – Debt and Financing Arrangements" in our Annual Report on Form 10-K for the year ended December 31, 2025 for a description of our debt and financing arrangements. Additionally, see "Risk Factors – Risks Related to Our Indebtedness" as described in our Annual Report on Form 10-K for the year ended December 31, 2025 for further discussion surrounding the risks and uncertainties related to our debt and financing arrangements.

**Dividends and Share Repurchase Program**

During the three months ended March 31, 2026, we paid dividends on our common stock of $15.9 million to our shareholders. During the second quarter of 2026, our board of directors declared a dividend of $0.255 per share of common stock to shareholders of record as of June 5, 2026 and payable on June 22, 2026.

As of March 31, 2026, our board of directors had authorized us to repurchase up to an aggregate of $1.25 billion of our issued and outstanding common stock since the share repurchase program was established in 2018. During the three months ended March 31, 2026, we repurchased 106,008 shares of our common stock at an average price of $94.12 for an aggregate of $10.0 million. As of March 31, 2026, we had $230.7 million remaining under the current share repurchase authorization.

See "Notes to Unaudited Condensed Consolidated Financial Statements – Note 10 – Common Stock," Item 1 of Part I to this report for a description of our share repurchase program.

**Capital Expenditures and Other Investments**

During the three months ended March 31, 2026, we invested $19.2 million in capital expenditures. We expect to invest approximately $95.0 million in capital expenditures for the full year, although actual amounts may vary depending upon a variety of factors, including the timing of certain capital project implementations and receipt of capital purchases. Capital expenditures generally relate to investments to support the manufacturing and distribution of products, our go-to-market activities, as well as investments in facilities to support our global strategic initiatives.

32

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

In addition, during the three months ended March 31, 2026, we invested $5.7 million in capitalized implementation costs associated with the implementation of a new global cloud-based ERP platform as part of our plans to integrate our operations and enhance our supply chain and finance capabilities. We expect to invest approximately $25.0 million in capitalized implementation costs associated with this global ERP platform for the full year.

**Cash Flows**

The following table presents the major components of net cash flows from operating, investing and financing activities for the periods indicated:

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 31,** | **March 31,** |
| ***(in thousands)*** | **2026** | **2025** |
| Cash flows from: |  |  |
| &nbsp;&nbsp;Operating activities | $(143663) | $(120254) |
| &nbsp;&nbsp;Investing activities | (19191) | (11263) |
| &nbsp;&nbsp;Financing activities | 164908 | 118145 |
| &nbsp;&nbsp;Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash | (463) | 912 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | $1591 | $(12460) |

---

***Cash Flows from Operating Activities***

The increase in cash used in operating activities was primarily driven by an increase in cash used to fund working capital requirements. At any specific point in time, working capital is subject to many variables, including seasonality and inventory management, the timing of cash receipts and payments, vendor payment terms and fluctuations in foreign exchange rates.

***Cash Flows from Investing Activities***&nbsp;&nbsp;&nbsp;&nbsp;

The increase in cash used in investing activities was driven by changes in capital expenditures.

***Cash Flows from Financing Activities***

The increase in cash provided by financing activities was primarily driven by an increase in net proceeds from credit facilities, as well as a decrease in purchases of common stock, offset in part by an increase in payments of employee restricted stock tax withholdings.

**Contractual Obligations and Off-Balance Sheet Arrangements**

During the normal course of business, we enter into agreements to purchase goods and services, including purchase commitments for advertising (including media placement and production costs), finished goods inventory, capital expenditures and endorsement arrangements with professional golfers. There have been no material changes to these purchase commitments since the year ended December 31, 2025.

As of March 31, 2026, other than as discussed above, we did not have any off-balance sheet arrangements that have, or are reasonably likely to have, a material current or future effect on our financial condition, results of operations, liquidity, capital expenditures or capital resources.

**Critical Accounting Estimates**

There have been no material changes to our critical accounting estimates from the information provided in Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations," included in our Annual Report on Form 10-K for the year ended December 31, 2025.

**Recently Issued Accounting Standards**

We have reviewed all recently issued accounting standards and have determined that, other than as disclosed in "Notes to Unaudited Condensed Consolidated Financial Statements – Note 1 – Summary of Significant Accounting Policies," Item 1 of Part I to this report, such accounting standards will not have a significant impact on our consolidated financial statements or otherwise do not apply to our operations.

33

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

***ITEM 3.****&nbsp;&nbsp;&nbsp;&nbsp;* ***Quantitative and Qualitative Disclosures About Market Risk***

***Interest Rate Risk***

We are exposed to interest rate risk under our various credit facilities which accrue interest at variable rates, as described in "Notes to Unaudited Condensed Consolidated Financial Statements – Note 5 – Debt and Financing Arrangements," Item 1 of Part I, to this report. Interest rate risk is highly sensitive due to many factors, including U.S. monetary and tax policies, U.S. and international economic factors and other factors beyond our control. We are exposed to changes in the level of interest rates and to changes in the relationship or spread between interest rates for our floating rate debt. Our floating rate debt requires payments based on a variable interest rate index. Increases in interest rates may reduce our net income by increasing the cost of our debt.

We performed a sensitivity analysis to assess the potential effect of a hypothetical movement in interest rates on our annual pre-tax interest expense. As of March 31, 2026, we had $657.5 million of outstanding indebtedness at variable interest rates. The sensitivity analysis, while not predictive in nature, indicated that a one percentage point increase in the interest rate applied to these borrowings as of March 31, 2026 would have resulted in an increase of $6.6 million in our annual pre-tax interest expense. This sensitivity analysis disregards fluctuations in balances of our outstanding variable rate indebtedness due to borrowings and repayments throughout the year.

***Foreign Exchange Risk***

We are exposed to foreign currency transaction risk related to transactions denominated in a currency other than functional currency. In addition, we are exposed to currency translation risk resulting from the translation of the financial results of our consolidated subsidiaries from their functional currency into U.S. dollars for financial reporting purposes.

We use financial instruments to reduce the earnings and shareholders' equity volatility relating to transaction risk. The principal financial instruments we enter into on a routine basis are foreign exchange forward contracts, pertaining to the U.S. dollar, the Japanese yen, the British pound sterling, the Canadian dollar, the Korean won, the Australian dollar and the euro. The periods of the foreign exchange forward contracts designated as hedges correspond to the periods of the forecasted hedged transactions, which do not exceed 24 months subsequent to the latest balance sheet date. We do not enter into derivative financial instrument contracts for trading or speculative purposes.

We performed a sensitivity analysis to assess potential changes in the fair value of our foreign exchange forward contracts relating to a hypothetical movement in foreign currency exchange rates. The gross U.S. dollar equivalent notional amount of all foreign exchange forward contracts outstanding at March 31, 2026 was $257.8 million, representing a net settlement asset of $3.5 million. The sensitivity analysis of changes in the fair value of our foreign exchange forward contracts outstanding as of March 31, 2026, while not predictive in nature, indicated that the net settlement asset of $3.5 million would decrease by $19.9 million resulting in a net settlement liability of $16.4 million, if the U.S. dollar uniformly weakened by 10% against all currencies covered by our contracts.

The sensitivity analysis described above recalculates the fair value of the foreign exchange forward contracts outstanding by replacing the actual foreign currency exchange rates and current month forward rates with foreign currency exchange rates and forward rates that reflect a 10% weakening of the U.S. dollar against all currencies covered by our contracts. All other factors are held constant. The sensitivity analysis disregards the possibility that foreign currency exchange rates can move in opposite directions and that gains from one currency may or may not be offset by losses from another currency. The analysis also disregards the offsetting change in value of the underlying hedged transactions and balances.

The financial markets and currency volatility may limit our ability to cost-effectively hedge these exposures. The counterparties to derivative contracts are major financial institutions with investment grade credit ratings. We monitor the credit quality of these financial institutions on an ongoing basis.

34

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

***Commodity Risk***

We are exposed to commodity price and availability risks with respect to certain materials and components used by us, our suppliers and our manufacturers, including polybutadiene, zinc diacrylate, urethane and ionomers for the manufacturing of our golf balls, tungsten, titanium and steel for our golf clubs, leather and synthetic fabrics for our golf shoes, golf gloves, golf gear and golf apparel, and resin and other petroleum-based materials for a number of our products.

***Impact of Inflation***

Our results of operations and financial condition are presented based on historical cost, and inflation in the cost of our products, overhead costs or wage rates may adversely affect our operating results. While it is difficult to accurately measure the impact of inflation due to the imprecise nature of the estimates required, we believe that inflation in the form of increased raw materials and other input costs, including inbound freight and wage rates, has at times impacted our business, results of operations, financial position and cash flows. In the future, sustained and higher inflationary environments, including increased raw material and other input costs, could materially impact our business, results of operations, financial position and cash flows.

***ITEM 4.****&nbsp;&nbsp;&nbsp;&nbsp;* ***Controls and Procedures***

<u>Evaluation of Disclosure Controls and Procedures.</u> Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the fiscal quarter ended March 31, 2026. Based on such evaluation, our principal executive officer and principal financial officer have concluded that as of such date, our disclosure controls and procedures were effective.

<u>Changes in Internal Control over Financial Reporting.</u> There were no changes in our internal controls over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter ended March 31, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

35

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

**PART II.**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **OTHER INFORMATION**

***ITEM 1.****&nbsp;&nbsp;&nbsp;&nbsp;* ***Legal Proceedings***

We are party to legal proceedings associated with the normal conduct of our businesses and operations. It is not possible to predict the outcome of the pending actions, and, as with any litigation, it is possible that some of these actions could be decided unfavorably.

***ITEM 1A.****&nbsp;&nbsp;&nbsp;&nbsp;* ***Risk Factors***

You should carefully consider each of the risk factors included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025, as well as the other information set forth in this report. There have been no material changes to the risk factors as described in our Annual Report on Form 10-K for the year ended December 31, 2025.

***ITEM 2.****&nbsp;&nbsp;&nbsp;&nbsp;* ***Unregistered Sales of Equity Securities and Use of Proceeds***

The following table provides information relating to the Company's purchase of common stock for the first quarter of 2026:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **Total number of shares purchased** | **Average price paid per share** | **Total number of shares purchased as part of publicly announced plans or programs** | **Approximate dollar value of shares that may yet be purchased under the plans or programs**<br> ***(in thousands)***  |
| January 1, 2026 - January 31, 2026 |  | $— |  | $240654 |
| February 1, 2026 - February 28, 2026 |  |  |  | 240654 |
| March 1, 2026 - March 31, 2026 | 106008 | 94.12 | 106008 | 230676 |
| **Total** | 106008 | $94.12 | 106008 |  |

---

***ITEM 3.****&nbsp;&nbsp;&nbsp;&nbsp;* ***Defaults Upon Senior Securities***

None.

***ITEM 4.****&nbsp;&nbsp;&nbsp;&nbsp;* ***Mine Safety Disclosures***

None.

***ITEM 5.&nbsp;&nbsp;&nbsp;&nbsp; Other Information***

None.

36

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

***ITEM 6.****&nbsp;&nbsp;&nbsp;&nbsp;* ***Exhibits***

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| <u>[10.](https://www.sec.gov/Archives/edgar/data/1672013/000167201326000057/ex105-rsuagreementxdirecto.htm)[1](https://www.sec.gov/Archives/edgar/data/1672013/000167201326000057/ex105-rsuagreementxdirecto.htm)[†](https://www.sec.gov/Archives/edgar/data/1672013/000167201326000057/ex105-rsuagreementxdirecto.htm)</u> | <u>[Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement for Directors under the Acushnet Holdings Corp. Amended and Restated 2015 Omnibus Incentive Plan (granted on or after February 12, 2026) (incorporated by reference to Exhibit 10.5 to the Registrant's Annual Report on Form 10-K filed February 27, 2026).](https://www.sec.gov/Archives/edgar/data/1672013/000167201326000057/ex105-rsuagreementxdirecto.htm)</u> |
| <u>[10.2†](https://www.sec.gov/Archives/edgar/data/1672013/000167201326000057/ex106-rsuagreementxcmcform.htm)</u> | <u>[Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under the Acushnet Holdings Corp. Amended and Restated 2015 Omnibus Incentive Plan (granted on or after February 12, 2026) (incorporated by reference to Exhibit 10.6 to the Registrant's Annual Report on Form 10-K filed February 27, 2026](https://www.sec.gov/Archives/edgar/data/1672013/000167201326000057/ex106-rsuagreementxcmcform.htm)[).](https://www.sec.gov/Archives/edgar/data/1672013/000167201326000057/ex106-rsuagreementxcmcform.htm)</u> |
| <u>[10.3†\*](https://www.sec.gov/Archives/edgar/data/1672013/000167201326000057/ex107-psuagreementxcmcform.htm)</u> | <u>[Form of Performance Stock Unit Grant Notice and Performance Stock Unit Agreement under the Acushnet Holdings Corp. Amended and Restated 2015 Omnibus Incentive Plan (granted on or after February 12, 2026) (incorporated by reference to Exhibit 10.7 to the Registrant's Annual Report on Form 10-K filed February 27, 2026).](https://www.sec.gov/Archives/edgar/data/1672013/000167201326000057/ex107-psuagreementxcmcform.htm)</u> |
| <u>[10.](https://www.sec.gov/Archives/edgar/data/1672013/000167201326000007/ex101-singaporejvagreement.htm)[4](https://www.sec.gov/Archives/edgar/data/1672013/000167201326000007/ex101-singaporejvagreement.htm)</u> | <u>[Subscription and Shareholders' Agreement between Acushnet Cayman Limited, Myre Overseas Corp. and ACL FootJoy Pte. Ltd. dated as of January 6, 2026 (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed January 8, 2026).](https://www.sec.gov/Archives/edgar/data/1672013/000167201326000007/ex101-singaporejvagreement.htm)</u> |
| <u>[31.1](ex311-10qxq12026.htm)</u> | <u>[Certification of Periodic Report by Chief Executive Officer under Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).](ex311-10qxq12026.htm)</u> |
| <u>[31.2](ex312-10qxq12026.htm)</u> | <u>[Certification of Periodic Report by Chief Financial Officer under Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).](ex312-10qxq12026.htm)</u> |
| <u>[32.1](ex321-10qxq12026.htm)</u> | <u>[Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).](ex321-10qxq12026.htm)</u> |
| <u>[32.2](ex322-10qxq12026.htm)</u> | <u>[Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).](ex322-10qxq12026.htm)</u> |
| 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH | Taxonomy Extension Schema Document |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | Inline XBRL Taxonomy Extension Labels Linkbase Document |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101) |

---

__________________________________

† Identifies exhibits that consist of a management contract or compensatory plan or arrangement.

\* Certain information has been redacted from this exhibit pursuant to Item 601(b)(10)(iv) of Regulation S-K because it is both not material and is the type of information that the registrant customarily and actually treats as private or confidential.

37

------

<u>[**Table of Contents**](#i26ac3c2f0d24498d958d61e65856c20f_7)</u>

**SIGNATURES**

&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | ACUSHNET HOLDINGS CORP. | ACUSHNET HOLDINGS CORP. |
| Dated: May 6, 2026 | By: | /s/ David Maher |
|  |  | David Maher |
|  |  | *President and Chief Executive Officer* |
|  |  | *(Principal Executive Officer)* |
| Dated: May 6, 2026 | By: | /s/ Sean Sullivan |
|  |  | Sean Sullivan |
|  |  | *Executive Vice President and Chief Financial Officer* |
|  |  | *(Principal Financial Officer)* |

---

38

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATIONS**

I, David Maher, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Quarterly Report on Form 10-Q of Acushnet Holdings Corp.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| Date: May 6, 2026 |
| /s/ DAVID MAHER |
| Name: David Maher |
| *President and Chief Executive Officer* |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATIONS**

I, Sean Sullivan, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Quarterly Report on Form 10-Q of Acushnet Holdings Corp.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| Date: May 6, 2026 |
| /s/ SEAN SULLIVAN |
| Name: Sean Sullivan |
| *Executive Vice President and Chief Financial Officer* |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION OF PERIODIC FINANCIAL REPORTS**

I, David Maher, President and Chief Executive Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)the Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 (the "Periodic Report"), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of Acushnet Holdings Corp.

Date: May 6, 2026

---

| |
|:---|
| /s/ DAVID MAHER |
| Name: David Maher |
| *President and Chief Executive Officer* |

---

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION OF PERIODIC FINANCIAL REPORTS**

I, Sean Sullivan, Executive Vice President and Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) the Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 (the "Periodic Report"), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of Acushnet Holdings Corp.

Date: May 6, 2026

---

| |
|:---|
| /s/ SEAN SULLIVAN |
| Name: Sean Sullivan |
| *Executive Vice President and Chief Financial Officer* |

---

<br>